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ABSTRACT 
 
PAG, the phosphoprotein associated with GEMs (glycosphingolipid-enriched 
microdomains) is a ubiquitously expressed transmembrane adaptor protein that 
negatively regulates Src-family kinases via the phosphotyrosine-dependent recruitment 
of Csk to the GEMs. Csk is a cytoplasmic protein tyrosine kinase that phosphorylates the 
C-terminal inhibitory tyrosine of Src kinases. Upon TCR engagement, PAG becomes 
dephosphorylated by a yet unknown phosphatase thus displacing Csk from the 
membrane and thereby enabling the activation of Src kinases (Fyn, Lck). Since Fyn is 
responsible for the majority of PAG phosphorylation, this provides a feed back loop, as 
the rephosphorylation of PAG recruits Csk to the membrane to inhibit the Src kinases.  
The aim of my thesis was to gain a better understanding of the regulatory 
function of PAG by studying the role of various motifs in GEM localisation and Fyn 
binding.  
Palmitoylation at the juxtamembrane CxxC motif is thought to target 
transmembrane adaptors into the lipid rafts. We have therefore studied the effect of a 
C→A mutation at this site within PAG in the Jurkat T-cell line, using both biochemical 
and functional assays. While the CxxC mutant is localized to the membrane, it does not 
target to the GEMs. However it becomes Tyr phosphorylated, binds Fyn, EBP-50 and 
recruits Csk to the membrane, similar to wt PAG. To monitor the effect of displacing PAG 
from the lipid rafts we studied the effects of the overexpressed palmitoylation mutant on 
CD3 and SDF-mediated signalling and as functional read outs we present proximal 
signalling studies, calcium flux measurements and migration assays. Migration assays 
show clear increase in migratory response of the cells overexpressing the CxxC mutant. 
Experiments obtained with siRNA further strengthen these data as suppression of PAG 
also leads to increased migration. 
Fyn is the kinase responsible for phosphorylation of PAG, but unlike Csk and 
EBP-50, the site of interaction between Fyn and PAG is still unknown. To study the 
mechanism of Fyn binding, several truncation and site directed mutants needed to be 
generated. Identification of the Fyn binding site should help us to better understand how 
the kinase interacts with its target protein and by mutating the site of interaction; we can 
study whether direct association is necessary for PAG phosphorylation and whether Fyn 
has an additional adaptor function. 
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REAGENTS AND RECIPES 
 
Vectors 
pGEM-5Zf(+) (Promega) 
pEF-IRES (1)
pEF-BOS (2) 
pCMS3-H1p-EGFP (D.D.Billadeau, Mayo Clinic, Minnesota, USA) 
 
Enzymes 
T4 Polynucleotide Kinase 10U/µl (NEB) 
DNA Polymerase I Large (Klenow) fragment 5U/µl (NEB) 
T4 DNA ligase 400U/µl (NEB) 
Taq DNA polymerase (NEB) 
Deoxynucleotide (dNTP) Solution Mix (NEB) 
Glycogene (Bioline) 
Aat II (NEB) 
Nco I (NEB) 
Nhe I (NEB) 
Not I (NEB) 
Sma I (NEB) 
Bgl II (NEB) 
Hind III (NEB) 
 
Chemically competent bacteria 
TYM media 
2% (w/v) tryptone peptone (DIFCO) 
0.5% (w/v) yeast extract (DIFCO) 
0.1M NaCl (Roth) 
10mM MgSO4 (Roth) 
 
TFB1 media 
30mM potassium acetate (Roth) 
50mM MnCl2 (Sigma) 
100mM KCl (Roth) 
10mM CaCl2 (Merck) 
15% (w/v) glycerin (Sigma) 
 
TFB2 media 
10mM Na-MOPS pH 7.0 (Roth) 
75mM CaCl2 (Merck) 
10mM KCl (Roth) 
15% (w/v) glycerin (Sigma) 
 
Bacterial culture 
LB Broth (Sigma) 
LB Agar (Sigma) 
Ampicillin (Sigma) 
IPTG (bts) 
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X-gal (Promega) 
 
SOC media 
20g tryptone peptone (Roth) 
5g yeast extract (Roth) 
10ml 1M NaCl (Roth) 
2.5ml 1M KCl (Roth) 
900ml H2O 
Autoclave the solution and cool it down to RT. Then add the rest of the components:  
10ml 1M MgCl26xH2O (filtered, Sigma) 
20ml 1M glucose (filtered, Sigma) 
 
DNA preparation 
MiniPrep Kit (Nucleo Spin Plasmid, Macherey-Nagel) 
MaxiPrep Kit (Nucleo Bond PC500EF Macherey-Nagel) 
Nucleo Spin Extract Kit (Macherey-Nagel) for elution of DNA fragments from agarose gel 
OD was measured with: Ultrospec 3000 (Pharmacia Biotech) 
 
Agarose gel 
50xTAE buffer (for 1 l) 
242g Tris base (Roth) 
57.1ml acetic acid (Baker) 
100ml 0.5M EDTA (Sigma) pH 8.0  
 
Agarose gel 1% (for 100ml) 
1g agarose (BioRad) 
100ml TAE buffer 
10µl etidium bromide (Roth) 
 
DNA loading buffer, blue (Bioline)  
 
Markers 
HyperLadder I, V (Bioline) 
GeneRuler 50bp DNA Ladder (Fermentas) 
 
Cell culture 
RPMI 1640 (Biochrom) 
Dulbecco´s MEM (Biochrom) 
FCS (Fetal Bovine Serum, PAN Biotech) 
PBS w/ Ca2+, Mg2+ (Biochrom) 
PBS w/o Ca2+, Mg2+ (Biochrom) 
DMSO (dimethyl-sulfoxide, Fluka) 
 
Flow cytometry 
Blocking buffer 
0.1% Na-aside (Roth)  
0.1% saponin (Sigma) 
0.2% BSA/c (1:500) (Aurion) 
10mg/ml BSA/PBS  
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Fixative/permeabiliser 
3.7% paraformaldehyde (Sigma) 
0.2% saponin (Sigma) 
in PBS 
 
Washing buffer 
Like blocking buffer but in 1xPBS 
 
Microscopy 
Trypan blue (Sigma) 
BSA/c (Aurion) 
 
Fixative (for 30 ml) for Jurkat cells 
8.7ml 12% paraformaldehide (final: 3.5%) (Sigma) 
21.3ml 1xPBS (Gibco) 
 
Fixative (for 30 ml) for adherent cells 
10ml 12% PFA (final: 4%) (Sigma) 
20ml 1xPBS pH 7.4 
6μl glutaraldehide (final 0.02%) (Sigma) 
 
Permeabilisation solution 
0.1% Triton X-100 (Packard) in PBS 
 
Embedding-medium 
2.45ml glycerin for fluorescent microscopy (Merck) 
2.45ml Vectashield (Vector Laboratories) 
100mg Dabco (= 1,4 diazabicyclo-octane, Sigma) in 100μl PBS (pH 8.9) 
 
Lysates and IPs 
Lysis buffer  
500mM Hepes (N-2-hydroxyethyl-piperazin-N-ethansulfon-acid, Serva) 
100mM NaCl (Roth) 
1% NP-40 (Nonidet P-40, Igepal, Sigma) 
5mM EDTA (Sigma) 
1mM Na-monovanadate (Merck) 
50mM NaF (Sigma) 
10mM Na-pyrophosphate (Sigma) 
1mM PMSF (=phenylmethylsulfonylfluride, Sigma) 
1% LM (=lauryl maltoside, Calbiochem) 
 
NP-40 washing buffer 
1% 0.5M EDTA (Sigma) 
5% 1M Tris pH7.4 (Roth) 
5% NP-40 (Igepal, Sigma) 
15% 1M NaCl (Roth) 
 
5x non-reducing sample buffer-NRSB (for 10 ml) 
50% glycerol (Sigma) 
330mM Tris, pH 6.8 (Roth) 
10% SDS (Calbiochem) 
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0.01% bromphenol blue (Roth) 
 
5x reducing sample buffer 
1ml NRSB 
50μl 2-mercaptoethanol (Sigma) 
 
Others 
PBS Dulbecco’s (Gibco)  
PP2 (Calbiochem) 
BSA (albumine, bovine serum, fraction V, Sigma) 
Anti-FlagM2-agarose (Sigma) 
Flag-peptide (Sigma) 
 
Gel electrophoresis and Western blot 
SDS-PAGE gel (for 10 ml, 10% separating gel) 
4.7ml water 
2.5ml 40% acrylamide/BIS (Bio-Rad) 
2.6ml 1.5M Tris-HCl pH8.8 (Roth) 
0.1ml 10% SDS (Calbiochem) 
0.1ml 10% APS (ammoniumperoxidisulphate, Roth) 
0.004ml TEMED (Roth) 
 
SDS-PAGE gel (for 3 ml stacking gel) 
2.19ml water 
0.375ml 40% acrylamide/BIS 
0.375ml 1M Tris-HCl pH6.8 
0.03 10% SDS 
0.03 10% APS 
0.003ml TEMED 
 
ProSieve gel (for 10 ml, 12%) 
4.9ml water 
2.4ml ProSieve 50 gel solution (Cambrex) 
2.5ml 1.5M Tris-HCl pH8.8 (Roth) 
0.1ml 10% SDS (Calbiochem) 
0.1ml 10% APS (Roth) 
0.004ml TEMED (Roth) 
 
Transblot solution (for 1l) 
5.80g Tris (Roth) 
2.90g glycine (Roth) 
0.37g SDS (Calbiochem) 
200ml methanol (Roth) 
 
10xTBS buffer (for 1l) 
80.0g NaCl (Roth) 
  2.0g KCl (Sigma) 
30.0g Tris (Roth) 
pH 8.00 
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Stripping buffer (for 200ml) 
40.0ml 10% SDS (Calbiochem) 
  1.4ml 2-mercaptoethanol (Sigma) 
25.0ml 0.5 M Tris, pH 6.7 
 
10x electrophoresis buffer for ProSieve gel (for 1l) 
121g Tris Base (Roth) 
179g Tricine (Roth) 
100ml 10% SDS solution 
 
Others 
10xTGS - electrophoresis buffer for SDS-PAGE gel (Bio-Rad) 
Ponceau S solution (Sigma)  
Tween-20 (Roth) 
Protein MW standard (Page Ruler Prestained Protein Ladder, Fermentas) 
ECL Kit (Amersham) 
 
Preparation of GEM fractions 
Sucrose (Sigma) 
 
Lysis buffer  
50mM Hepes, pH 7.4 (N-2-hydroxyethyl-piperazin-N-ethansulfon-acid, Serva) 
100mM NaCl (Roth) 
3% Brij 58 (Pierce) 
5mM EDTA (Sigma) 
1mM Na-monovanadate (Merck) 
50mM NaF (Sigma) 
10mM Na-pyrophosphate (Sigma) 
1mM PMSF (=phenylmethylsulfonylfluride, Sigma) 
 
MNE buffer, pH 6.5 
25mM MES (Sigma) 
5mM EDTA (Sigma) 
150mM NaCl (Roth) 
 
Kinase Assay 
[γ32P] ATP 3000Ci/mM (Amersham) 
Enolase (Sigma) 
Kinase buffer 
50mM Tris-HCl pH 7.5 
10mM MnCl2 (Sigma) 
0.1% NP-40 (Sigma) 
 
Migration Assay 
Human SDF-1α (TEBU) 
Transwell inserts 5μm pore size (Costar) 
 
Assay medium (in RPMI) 
20mM Hepes buffer (Biochrom)  
1% BSA (Sigma)  
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METHODS 
 
Oligo phosphorylation 
Aat II-CD8/Flag-Nco I oligonucleotides (synthesised by Thermo electron corporation):  
w: 5’ catggccttaccagtgaccgccttgctcctgccgctagccttgctgctccacgccgccaggccggactacaaggac 
gacgatgacaaggc 3’ 
rev: 5’ catggccttgtcatcgtcgtccttgtagtccggcctggcggcgtggagcagcaaggctagcggcaggagcaagg 
cggtcactggtaaggccatgacgt 3` 
 
The oligos have been dissolved to a final concentration of 2µg/µl at 37°C, 15min. Then 
12.5µl from both oligos were mixed with 3µl T4 DNA ligase buffer and 2µl polynucleotide 
kinase and incubated at 37°C overnight. The mixture was shortly centrifuged (10sec, 
14000rpm, RT), 1 volume (30µl) dH2O and 2 volumes (60µl) of 
phenol/chloroform/isoamylalcohol (25:24:1) were added to it. Following 1min 
centrifugation on 14000rpm, at RT the upper phase was transferred to a new tube and 
the DNA was precipitated by adding 1.5µl glycogen, 1/10 volume co-precipitation buffer 
(Bioline) and 2 volumes of cold absolute ethanol (96%, -20°C). Precipitation was carried 
out at –70°C for 30min and was followed by 15min centrifugation (14000rpm, 4°C). 
Pellet was washed with 200µl 70% ethanol, dried for 10min and resuspended in 25µl 
dH2O. 
Ligation 
a) Vector (pGEM-5Zf Aat II/Nco I digested, alkaline phosphatase treated): 40ng 
Insert (phosphorylated CD8-Flag oligonucleotide): 1.5µg 
b) Vector (CD8-Flag/pGEM Nco I/Not I digested, alkaline phosphatase treated): 40ng 
Insert (PAG Nco I/Not I digested): 80ng 
c) Vector (pEF-IRES Sma I/Not I digested, Klenow and alkaline phosphatase treated): 
60ng 
Insert (CD8-Flag/PAG Aat II/Not I digested, Klenow treated): 120ng 
 
T4 DNA ligase (NEB): 1µl (400U) 
T4 DNA ligase buffer (NEB): 1/10 volume 
BSA: 0.3µl 
The mixture was incubated for 10min at RT. 
 
When blunt end ligation was carried out hexamino-cobalt-cloride (Sigma) was added to 
the reaction up to 10µM final concentration and was incubated for 2 hours at RT. 
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Site directed mutagenesis 
QuikChange Mutagenesis Kit (Stratagene) was used according to the manufacturer’s 
instructions.  
Primers used to generate C37,40S double mutant of N-terminally Flag-tagged PAG: 
SxxS  fw: 5´cttcctcatcttcctgtcctctagttctgacaggg 3´ 
 rev: 5´ccctgtcagaactagaggacaggaagatgaggaag 3´ 
 
Primers used to insert stop codons into the sequence of N-terminally Flag-tagged PAG: 
STOP1 fw: 5´acagcatagtggggaccattagaacctgatgaacgtgc 3´ 
  rev: 5´gcacgttcatcaggttctaatggtccccactatgctgt 3´ 
 
STOP2 fw: 5´gatctgctggattcctaggacagcacagggaaac 3´ 
  rev: 5´gtttccctgtgctgtcctaggaatccagcagatc 3´ 
 
STOP3 fw: 5´cgtcaaagtgttaatgtatagagtatccttggaaattc 3´ 
  rev: 5´gaatttccaaggatactctatacattaacactttgacg 3´ 
 
STOP4 fw: 5´gctactgttaaagacttctaaaaaactccaaacagcac 3´ 
  rev: 5´gtgctgtttggagttttttagaagtctttaacagtagc 3´ 
 
Primers used to generate P134A, P137A double mutant at the membrane proximal 
proline rich region of PAG: 
PxxP  fw: 5´cgggagctggccagaatcgctcccgagagc 3´ 
 rev: 5´gctctcgggagcgattctggccagctcccg 3´ 
 
Primers used to generate Y105F mutant of PAG: 
Y105F fw: 5´ggacgtacgtcgtaaagctccttcaggtctg 3´ 
 rev: 5´cagacctgaaggagctttacgacgtacgtcc 3´ 
 
Primers used to generate T430A mutant within the EBP-50 binding motif: 
T→A fw: 5´gcaaggcagagatattgccaggctctagcaacc 3´ 
 rev: 5´ggttgctagagcctggcaatatctctgccttgc 3´ 
 
Digestion of DNA with restriction enzymes 
Single digestions were carried out in 20µl end volume, double digestions in 50µl. 
Reactions were supplemented in each case with 0.3µl or 0.6µl BSA, respectively. The 
optimal amount of restriction enzymes for proper digestion of certain DNAs was 
adjusted: 4U Aat II/µg DNA, 2U Nco I/µg DNA and 3U Not I/µg DNA). 
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In the case of double digestions of the pGEM vector, 4U / µg DNA was used from both 
enzymes (Aat II, Nco I). For cutting pEF-IRES 1U Sma I and Not I / µg DNA was 
sufficient. 
Klenow treatment of DNA fragments 
The DNA fragments have been extracted from the gel before blunt end ligation and 
alkaline phosphatase treatment. 440ng of digested and gel extracted DNA or 5µg of 
digested DNA was treated with Klenow enzyme. 33µM dNTP and 1/10 volume buffer 2 
(NEB) was added and the reaction was carried out at 25°C for 15min. The enzyme 
activity was blocked by incubating the reaction for 20min at 75°C.  
When alkaline phosphatase treatment was required, 2µl (2U/µl) alkaline phosphatase 
was added to the Klenow treated DNA (following the inactivation of the Klenow enzyme) 
and was incubated for additional 1 hour at 37°C. 
Preparation of chemically competent cells 
A single bacterial colony was picked and grown in 20ml TYM media for 5 hours (OD 0.2-
0.8). Then 2.5ml of bacterial suspension was inoculated into 100 ml TYM media and 
cultured until OD 0.2-0.8 was achieved (ca.1-2 hours). 500ml media was added and the 
bacteria were further cultured to OD 0.6 (ca.1 hour). Prior to pelleting the bacteria 
(20min, 4200rpm, 4°C) the culture was cooled down to 4°C with constant shaking. 
Bacteria were carefully resuspended in 100ml ice-cold TFB1 and centrifuged for 8min. 
The pellet was resuspended in 20ml ice-cold TSB2 and aliquoted. Aliquots were stored 
at -70°C.  
Transformation of chemically competent E.coli 
50-100µl chemically competent bacteria were added to the ligation reaction and the 
mixture was kept on ice for 15min. This was followed by the heat shock step at 42°C for 
1min and 10min on ice. After adding 250µl SOC media, bacteria were grown for at least 
1 hour at 37°C, under constant shaking at 300rpm. Then they were spread onto 
prewarmed LB agar amp+ plates and grown overnight at 37°C. 
PCR (for screening the colonies after ligation) 
Primers 
Primer 1: 5’- ccgatgtctggacttcctcg -3’ 
Primer 2: 5’- gctgctccacgccgccag -3’ 
Primer 3: 5’- tgtgacagggaaaagaagccgcga -3’ 
Reaction:  
      primer 1      2µl (100µM) 
      primer 2      1µl (100µM) 
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      primer 3      1µl (100µM) 
 Taq polymerase 0.2µl (4U/µl) 
 buffer      1/10 volume 
 dNTP      1µl (10mM stock) 
 DMSO      1/10 volume 
 H2O       up to 50µl 
To each reaction 1 bacterial colony or 100ng DNA was added. 
Program: 95°C  5’ 
      30 x  95°C 1’ 
   50°C 1’ 
   72°C 1’ 
      72°C 10’ 
        4°C ∝ 
Constructs 
The following constructs were used in this study: FLAG-TRIM/pEF-BOS (3), FLAG-
PAG/pEF-BOS (4), and FLAG-C37,40A-PAG/pEF-BOS. The PAG CxxC mutant 
construct was generated using the QuikChange™ site-directed mutagenesis kit 
(Stratagene) according to the manufactures instructions with wild type C-terminally 
FLAG tagged PAG as the template. Lck-CFP was kindly provided by Dr. Wolfgang 
Paster (Medical University, Wien, Austria). 
Cell culture  
Jurkat T-cells (human peripheral T-cell leukaemia cell line) (Kab14 and JCam1.6) were 
maintained in RPMI 1640 medium supplemented with 10% FCS at 37°C, 5% CO2 in a 
humidified atmosphere. HEK 293T cells (human transformed primary embryonal kidney 
cell line) were maintained in Dulbecco´s modified Eagle medium (DMEM) supplemented 
with 10% FCS. 
Transfection  
Jurkat T-cells (20x106 at a density of 2-4x105 cells/ml) were centrifuged (1200rpm, 5min, 
RT) and the pellet washed once in PBS w/ Ca2+, Mg2+. Following washing, the cells were 
resuspended in PBS w/ Ca2+, Mg2+. DNA (30µg) was added to the cell suspension and 
electroporated (BTX cuvette gap size 4mm, Qbiogene) (230V, 950µF) using a Bio-Rad 
Gene Pulser II. After removing the DNA aggregates from the cuvette, transfected cells 
were added to 40ml medium and cultured for 20-24 hours at 37°C. 
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Flow cytometry 
Intracellular staining: 0.5x106 cells were centrifuged for 5min, 1200rpm, at 4°C. The 
pellet was resuspended in 100µl Fix/Perm solution and incubated for 15min at RT. Fixed 
and permeabilised cells were washed. Following a blocking step (15min in blocking 
buffer) the cells were incubated with primary antibody for 45min at RT (dilutions made in 
blocking buffer). After two additional washing steps, secondary antibody was added 
(dilutions made in blocking buffer) and incubated for 30min at RT. Again the samples 
were washed twice and finally the cells were resuspended in 400µl PBS and measured 
with FACS Calibur machine [BD]. Data were analyzed using the Cell Quest Pro Software 
package. 
Extracellular staining: 0.5x106 cells were washed with PBS as described above, without 
fixation and permeabilisation the cells were incubated with primary antibody (dilutions 
made in 1xPBS) for 20min at 4°C. Following two washing steps with PBS, samples were 
incubated with secondary antibody for 20min at 4°C. The final steps were carried out as 
described for intracellular staining. 
Microscopy 
1.4x105 cells were washed in RPMI 1640 medium. Pellets were resuspended in the 
same media to 7x106 cells/ml. 20µl of cell suspension was pipetted per spot onto a 12 
spot slide (Marienfeld) and incubated at 4°C for 10min to allow the cells to attach. The 
remaining cell suspension was then washed away in PBS. Cells were fixed (20min) and 
permeabilised for 1min. The slide was washed 3 times in 1xPBS. Before staining a 
blocking step was included with 5% BSA/PBS or horse serum/PBS for 15min, at RT to 
avoid unspecific binding of the antibody. Cells were stained for 60min in a wet chamber 
at RT. After 3x5min washing the cells were stained with FITC labelled secondary 
antibody for 60min in a wet chamber. Following three additional washing steps the 
samples were embedded in mounting media (Vectashield, Glycerol, 2% Dabco™ [1:1:1]) 
and the cover slip fixed to the slide with nail polish.  
The cells were visualized using a Leica DMRE-7 white-field fluorescence microscope 
with a 1.4/63x objective using a Spot RT camera [Diagnostic Instruments] and the Spot 
RT acquisition software. Deconvolution was performed using Metamorph (version 6.1, 
Universal Imaging). Images were processed using the InfranView software (version 
3.95). 
Confocal images were acquired using a Leica DMIRE2 microscope and processed with 
the LSM Image browser software (Zeiss). 
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Cell lysis  
After washing with 1ml cold PBS, 1x106 cells were lysed in 30µl lysis buffer for 30min on 
ice. Samples were centrifuged at 13000rpm for 15min at 4°C. The post-nuclear 
supernatant was then heated for 5min at 95°C with 5x reducing sample buffer. 
Immunoprecipitation  
Cells (5x106) were lysed in ice-cold lysis buffer for 30min on ice. After centrifugation 
(13000rpm, 15min, 4°C), the post-nuclear supernatant was taken and 60μl anti-FLAG 
M2 affinity gel (50% slurry) was added (murine IgG1 monoclonal antibody covalently 
attached to agarose) that was washed before usage according to manufacturer’s 
instructions. To reduce non-specific binding, 1/10 volume of 10mg/ml BSA was added. 
The samples were incubated on a rotating wheel minimum 2 hours or overnight at 4°C. 
After washing 5x in 1ml ice cold NP-40 washing buffer, the FLAG-tagged constructs 
were competitively displaced from the anti-FLAG agarose by incubating with 30μl 
100μg/ml FLAG peptide for 30min at 37°C. The agarose was pelleted by centrifugation 
and the supernatant cooked with 5x reducing sample buffer for 5min at 95°C.  
Gel electrophoresis and Western blotting  
Lysates and IPs were separated on 10% SDS-PAGE gel  at 130V and transferred onto 
nitrocellulose membranes (Hybond-C Extra, Amersham) with 140mA (2.2 mA/cm2), 
75min. After blocking in 5% milk for 1 hour and washing 1x in TBS/0,1% Tween-20, 
membranes were probed with primary antibody and the appropriate horseradish 
peroxidase-conjugated secondary antibody (dilutions indicated in Appendix). Membranes 
were washed 3x5min in TBS/Tween between and after staining with secondary antibody. 
Samples were visualized with an enhanced chemiluminescence (ECL) detection system 
according to the manufacturer’s instructions. 
12% ProSieve gels were prepared with ProSieve®50 gel solution and transferred onto 
PVDF Westran membrane (Schleicher & Schuell). Prior transfer the membrane was 
methanol treated according to the manufacturer’s instructions. 
Quantification of scanned blots was done with Kodak 1D Image Analysis Software. 
GEM fractionation 
GEM fractions were isolated by sucrose gradient centrifugation as previously described 
(4). Briefly, 20-30x106 cells were lysed in 0.5ml lysis buffer for 10min on ice. The lysate 
was then mixed (1:1) with 80% sucrose in MNE buffer and dounced 10 times. The 
suspension was transferred to ultracentrifuge tubes [Sorvall] and overlaid with 2ml 30% 
sucrose in MNE and 1ml 5% sucrose in MNE. Samples were centrifuged in Sorvall 
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Centrifuge rotor TH 660 on 200000xg, 4°C, for 20 hours and the centrifuge was stopped 
without brake. Fractions (9 x 400µl) were collected from the top of the gradient. All 
solutions were ice cold and all steps were performed on ice. 
In vitro kinase assay 
IPs were washed 5x in NP-40 washing buffer (as described above) and the samples 
divided into two equal aliquots. Both were pelleted and one cooked in 1xRSB for 5min at 
95°C and used for Western blotting, the other was resuspended in kinase buffer 
supplemented with acid-denatured enolase as substrate and P32 and incubated for 5min 
at RT. 5x reducing sample buffer was added and after cooking for 5min at 95°C samples 
were separated on 10% SDS-PAGE gels. After drying, the gels were exposed to 
autoradiography film (Kodak, BioMaxLight Film). 
Migration assay 
The cells were washed (900rpm, 5min) in migration media and resuspended at 5 x 106 
per ml. 600µl migration media was pipetted into the wells of a 24-well plate. Transwell-
inserts of 5μm pore size containing 100µl (5x105 cells) of cell suspension were placed 
into the media containing wells and equilibrated for 1 hour at 37°C. The transwell inserts 
were removed carefully and SDF-1 chemokine was added to the lower chamber to 
100ng/ml final concentration and the plate was incubated for 4 hours at 37°C. Migrated 
cells were collected from the lower chamber and counted with a FACS Calibur (for 
60sec). 
Calcium measurements 
Jurkat T-cells were transfected with either empty vector or the appropriate Flag-tagged 
PAG construct together with a vector containing GFP. 24 hours after transfection, 2x106 
cells were washed in RPMI 1640 without phenol red and loaded with Indo-1/AM 
(Molecular Probes/Invitrogen) for 45min at 37oC. The cells were briefly washed and 
incubated an additional 30min before measuring the FL4 (510/20nm) vs. FL5 
(400/40nm) ratio on a flow cytometer [BD LSR1]. The measurement was gated upon the 
GFP positive population. During the measurement, the cells were stimulated first with 
either anti-TCR [C305] (1:50) or SDF-1 [150ng/ml] and finally with ionomycin [2µg/ml]. 
siRNA 
The following oligos were used for siRNA design: 
Fw: 5’ gatccccgcgatacagactctcaacattcaagagatgttgagagtctgtatcgctttttggaaa 3’  
Rev: 5’ agcttttccaaaaagcgatacagactctcaacaagagaactttgttgagagtctgtatcgcggg 3' 
The 19 nt long target sequence corresponds to the sense strand of the generated siRNA 
(gcgatacagactctgaaca), which in turn corresponds to a 19 nt sequence within the mRNA 
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of PAG. The oligos (1µl) were annealed in 48µl annealing buffer (100mM NaCl, 50mM 
HEPES pH5.4) at 90°C for 4min and then kept on 70°C for 10min. The annealing was 
followed by stepwise cooling to 37°C (within 15-20min) and then further to 10°C or RT. 
The annealed oligos were ligated into pCMS3-H1p-EGFP vector that was previously 
linearised by Bgl II/Hind III digestion and gel purified on 1% agarose gel. The ligation 
reaction contained 2µl oligos, 1µl vector, 1µl T4 DNA ligase, 1µl T4 DNA ligase buffer 
and 5µl H2O. It was carried out overnight at RT. Afterwards the plasmids were treated 
with Bgl II for 30min at 37°C. Upon successful cloning the Bgl II site is destroyed, so that 
the insert containing plasmids will be resistant to the digestion reaction. The recombinant 
vector was transformed into competent cells as described above and the clones were 
tested for the presence of the right plasmids via digestion with EcoR I and Hind III.  
Jurkat T-cells were transfected with the siRNA containing plasmid as described above. 
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INTRODUCTION 
 
Multicellular organisms are shielded against pathogens by the immune system. The 
innate immune system is the first level of defence, which is immediate and non-specific. 
The specific immune answer is provided by the cellular and humoral elements of the 
acquired immune system and takes days. During phylogenesis, acquired immunity 
developed in higher Eukaryotes based upon the innate immunity. The elements of the 
innate and acquired immune system are interwoven and strongly cooperate with each 
other. The innate immune cells (macrophages, dendritic cells) that recognise, process 
and present antigen are initiating the specific answer of the acquired immunity. The 
innate immunity is also involved in the effector phase of immune reaction via the 
complement system, macrophages and granulocytes. (5) 
Generation of an effective adaptive immune response involves two major groups 
of cells: professional antigen presenting cells (APC: dendritic cells, monocytes, 
macrophages, B-cells) and lymphocytes. Antigen presentation is a process in which 
peptides (derived from proteins) are bound to MHC molecules and presented on the cell 
surface. Whether an antigen will be processed and presented together with class I or 
class II MHC molecules is determined by the route that the antigen takes to enter the 
cell.(5, 6)  
Specificity, diversity, and memory within the immune system are provided by the 
lymphocytes. Three groups of lymphocytes can be distinguished according to their 
morphology and function: T lymphocytes (T-cells), B lymphocytes (B-cells) and natural 
killer (NK) cells. The latter plays a role in the innate (non-specific) immune response, 
while T- and B-cells (T stands for thymus, B for bursa Fabricii, the organ in birds, where 
B-cells were first isolated) are the cellular components of acquired (specific) immunity. 
While B-cells are able to recognise a variety of antigens, from native proteins, lipids, 
carbohydrates, artificial compounds and metals, T-cells are specialised, recognising only 
peptides presented in the context of MHC-peptide complexes. (5) 
After they arise from haematopoietic stem cells in the bone marrow, T 
lymphocyte precursors migrate to the thymus to mature. Maturation into 
immunocompetent cells involves the random rearrangement of a series of gene 
segments encoding the cell’s antigen receptor. Each matured T-cell expresses 
approximately 105 T-cell receptor (TCR) on its surface with each of these having the 
identical specificity for antigen. The process of random rearrangement of the genes 
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encoding the TCR is capable of generating enormous diversity: 1015 unique receptor 
specificities. This huge diversity is later diminished through selection in the thymus, 
which ensures that only T-cells with functional receptors possessing low recognition of 
self antigens presented by MHC molecules will be able to mature. (6) Identification of the 
genes encoding the TCR occurred in the early 1980s. Since that time the structure of 
this protein complex has been described, and the events that occur following 
engagement of the TCR have been extensively studied.  
 
1. T cell signalling 
1.1. The T cell receptor 
Based upon the structure of the T-cell receptor, one can distinguish two T-cell 
populations: αβ and γδ T-cells. The latter have a different expression pattern (gut, skin) 
and role within the immune system and will not be discussed further. αβ T-cells (90-95% 
of human T-cell population) can be further divided into subpopulations based upon the 
expression of cell surface markers (CD4+ T helper cells and CD8+ T cytotoxic cells) and 
effector functions (TH1 cells - that mediate inflammatory responses and activate TC cells; 
TH2 cells - that are responsible for antibody production and involved in the fight against 
extracellular bacteria, parasites and toxins; TC cells - that eliminate viruses and tumour 
cells; and Treg cells – that suppress T-cell mediated immune responses). An activated T 
helper cell becomes an effector cell secreting various cytokines, which play a role in 
activating B- cells, TC cells and macrophages that participate in the immune response. In 
contrast to TH cells, cytotoxic T-cells do not secrete many cytokines, but instead exhibit 
cytotoxic activity against cells that are virus infected, tumour cells or foreign tissue graft. 
(5, 7)  
 The TCR heterodimer (α, β chains) is responsible for antigen recognition. The 
positively charged amino acids within the transmembrane domain of the α and β chains 
destabilise the heterodimer, so that it cannot exist in the membrane without associating 
with the chains of the CD3 complex (γ, δ, ε). Beside the CD3 chains, two ζ chains are 
also a central part of the TCR/CD3 complex. These and the α and β chains are bonded 
with a disulphide bridge (5). With its short cytoplasmic domains the TCR is unable to 
initiate signal transduction. Thus, the CD3 complex not only regulates the surface 
expression of the TCR, but also mediates signal transduction (8). The cytoplasmic tails 
of its associated chains contain 10 specific motifs, which were described by Reth (9) and 
later named immunoreceptor tyrosine-based activation motifs (ITAMs). The consensus 
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sequence of these motifs is: YXX(L/I/V)X6-8YXX(L/I/V) where X represents any amino 
acid. Tyrosines embedded in this motif are both necessary and sufficient for the initiation 
of downstream signalling. The ITAM mediated signals are critical at distinct stages of T-
cell development and for activation of effector functions (10).  
 α β
ζ ζ
εε δ γ
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Figure I. The TCR/CD3 complex 
The TCR heterodimer consists of the α and β chains that associate with the 
chains of the CD3 complex (γ, δ, ε). The two ζ chains are in central position and 
bind the α and β chains with a disulphide bridge. Black boxes represent ITAMs. 
 
1.2. Signal transduction from the TCR 
Following interaction of the TCR/CD3 complex with the antigen-derived peptide:MHC 
complex presented on the surface of an antigen presenting cell, receptor aggregation 
occurs. The receptor aggregates (TCRs, CD4 or CD8) formed after interaction with the 
ligand move to the lipid rafts (also known as glycosphyngolipid-enriched microdomains - 
GEMs) (11). Co-receptor dimerisation occurs (12), and plays a role in mediating 
prolonged cell contact with the APC (13). The Src kinase Lck (lymphocyte-specific 
cytoplasmic protein tyrosine kinase) is constitutively associated with CD4/8, and is more 
active when associated with a CD4/8 receptor dimer than compared with the monomer 
(13). Thus, beside the recruitment of pre-activated Lck, CD4/8 dimerisation plays a role 
in initiating and maintaining the active signalling machinery (13). Activated Lck 
phosphorylates the ITAMs providing binding sites for the tandem SH2 (Src homology 2) 
domains of the Syk kinase ZAP-70 (Zeta-associated protein of 70 kDa) and it activates 
the other Src kinase Fyn (14), ZAP-70 and the Tec family kinase Itk (interleukin-2 
inducible T-cell kinase) through phosphorylation (15). These kinases propagate the 
signal by phosphorylating and activating their substrates: various adaptor proteins and 
enzymes. The transmembrane adaptor protein LAT (linker for activation of T-cells) is 
phosphorylated by ZAP-70. This leads to the recruitment of Grb2 (growth factor receptor 
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bound protein 2) - SOS (son of sevenless homologue) a complex that is involved in the 
activation of the Ras-Erk (extracellular signal-regulated protein kinase) pathway. GADS 
(Grb2 related adaptor protein) binds to LAT via its SH2 domain and to SLP-76 (SH2 
domain containing leukocyte protein of 76 kDa) via an SH3 domain bringing these two 
key signalling proteins together. The inositol phospholipid specific phospholipase C-γ1 
(PLCγ1) also binds to phospho-LAT via its SH2 domain. LAT bound SLP-76 undergoes 
phosphorylation by ZAP-70. The phosphorylated SLP-76 then binds Itk, which in turn 
activates PLCγ1 by phosphorylating it. The activated PLCγ1 enzyme hydrolyses PIP2 
(phosphatidylinositol 4,5-biphosphate) to IP3 (inositol 1,4,5-triphosphate) and DAG 
(diacylglycerol). IP3 induces calcium release from the intracellular stores via interaction 
with a specific receptor located on the surface of the endoplasmatic reticulum, which 
leads to activation of calcium dependent enzymes like calcineurin. Calcineurin 
dephosphorylates NFAT (nuclear factor of activated T-cells) allowing its translocation 
into the nucleus. DAG activates PKCθ (protein kinase C), which is involved in NFκB 
(nuclear factor κB) activation, and RasGRP (Ras guanyl-releasing protein), which is a 
guanine-nucleotide exchange factor responsible for Ras activation that in turn leads to 
AP-1 (activator protein 1) activation via the MAPK (mitogen-activated protein kinase) 
pathway. The transcription factors NF-AT, AP-1 and NFκB initiate the transcription of IL-
2 and the IL-2R genes. Beside PLCγ1 activation, SLP-76 is involved in regulation of the 
actin cytoskeleton and adhesion via its associating partners ADAP (adhesion and 
degranulation promoting adaptor protein), VAV (guanine nucleotide exchange factor) 
and the Nck (non-catalytic region of tyrosine kinase)-PAK (p21 activating kinase)-WASP 
(Wiskott-Aldrich syndrome protein) complex. (reviewed in (15)) 
 
1.3. Costimulation 
T-cell responses require not only signals generated via the TCR, but costimulatory 
signals are also crucial for full activation. CD28 is the major positive costimulatory 
molecule. Its ligands (B7.1 and B7.2 also known as CD80 and CD86, respectively) are 
highly expressed on activated APCs. CD28 mediated signals contribute to the 
generation of stable T cell-APC conjugates by recruiting crucial signalling elements to 
the contact area (16).  
 There are two models for the mechanism of costimulation. In one CD28 has a 
unique signalling “voice” as it is able to activate several molecules (e.g. PI3K, Itk, 
p62Dok), initiates actin cytoskeletal rearrangement, plays a role in adhesion and controls 
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early and late effectors of anti-apoptotic programs. The other model considers CD28 as 
an amplifier of TCR signalling (17, 18) via strengthening the T cell-APC contact (the APC 
expresses 100-1000 times more B7 then pMHC) (18), via contribution to full activation of 
PLCγ1 through the PI3K/PIP3/Itk activation pathway (19), via amplifying Vav-mediated 
processes (18) and via contributing to strong activation of the main transcription factors 
involved in immediate and early gene expression. As one can see there are several 
places in the molecular network where the signals mediated via TCR and the 
costimulatory signals interweave leading to a synergised effect on gene transcription and 
effector functions of the T-cell reviewed in (20). Figure II. presents some elements of 
these two pathways and highlights the meeting points between them.  
  
 
Figure II. TCR and CD28 signalling with meeting points 
The signalling cascades induced by peptide stimulation and costimulation interweave leading to a synergised 
effect on gene transcription and effector functions of the T-cell. The costimulatory signal contributes to T-cell 
activation by activating PI3K and Itk thus playing a role in full activation of PLCγ1. Via amplifying Vav mediated 
processes it plays a role in actin cytoskeleton rearrangement, adhesion and migration. Signals generated via TCR 
and CD28 interact also on transcriptional level. Both pathways induce NFAT translocation to the nucleus (via 
PLCγ1 activation and inducing calcium mobilisation), NFκB activation (via PKCθ) and AP-1 activation (via PKCθ 
and the MAP kinases). 
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2. Lipid rafts 
The fluid mosaic model of Singer and Nicolson (21) describes the plasma membrane as 
a phospholipid bilayer. They realised that lateral diffusion of membrane components (i.e. 
lipids and proteins) occurs within the bilayer and that these components are also able to 
aggregate. The biggest breakthrough of this model compared to the preceding view was 
that it considered the membrane as a dynamic structure. The weak point of it was that it 
models the membrane as a random two-dimensional liquid. In the last three decades 
biological and model membranes were extensively studied and the results led to the 
need for modification of the fluid mosaic model. The data indicated that the plasma 
membrane has a heterogeneous structure with functional compartmentalisation (protein 
complexes, lipid compositional areas) in which components are not randomly distributed. 
The current view is that the thickness and patchiness of the membrane are variable and 
the protein occupancy is higher than previously thought. (22) 
 Regarding the lipid rafts, the currently accepted model is the raft hypothesis by 
Simons and Ikonen (23) which defines the rafts as “dynamic clustering of sphingolipids 
and cholesterol that move within the fluid bilayer” and function as “platforms for the 
attachment of proteins during signal transduction˝.   
 Lipid rafts were found to play a role in various biological processes, including 
several signalling pathways (e.g. TCR, BCR, IgE receptor, neurotropic factors, growth 
factors, chemokines, interleukins and insulin), vesicle trafficking (endocytosis), 
apoptosis, adhesion and migration. They were also described as entry sites for some 
viruses (e.g. HIV- human immunodeficiency virus), bacteria (e.g. E. coli to phagosomes, 
mycobacteria to macrophages) and toxins (e.g. cholera toxin) (24). Rafts also support 
the assembly (e.g. measles virus (25)) and budding (e.g. HIV (26)) of some viruses, the 
formation of prions and Alzheimer amyloids (27) were also localised to the lipid 
microdomains. Lipid rafts either serve the pathogen’s interest by providing site for 
receptor clustering (pore forming toxins) thereby increasing binding affinity or promoting 
toxin oligomerisation, or by providing link to the actin cytoskeleton (E. coli) (24). 
 
2.1. Structure of the lipid rafts 
The lipid composition of the plasma membrane differs from that of the intracellular 
membranes as it contains high levels of sterols (mainly cholesterol) and sphingolipids. 
Sphingolipids (originating from the Golgi) have a ceramide backbone and depending 
upon the attached head group, one can distinguish sphingomyelin (with a 
phosphocholine head group) from glycosphingolipids (with a carbohydrate head group). 
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Sphingolipids are present in the exoplasmic leaflet of the plasma membrane and 
possess two saturated chains. They associate with each other via weak interactions of 
their head groups. The head groups occupy larger areas than the chains. Thus, the 
forming interspaces are filled with cholesterol. Sterols are synthesised in the 
endoplasmatic reticulum (ER) and have the capability of flipping between the outer and 
inner leaflet of the membrane. According to the cholesterol content of the membrane two 
types of liquid phases exist: liquid-ordered (lo) and liquid-disordered (ld). The third group 
of lipid components of the plasma membrane are glycerophospholipids composed of a 
glycerol backbone with two acyl chains, one of which is saturated. Some of them, like 
phosphatidil inositol are restricted to the cytoplasmic leaflet. Raft assembly can occur at 
the earliest in the Golgi apparatus where sphingolipids are synthesised. Transmembrane 
proteins and GPI-anchored proteins incorporate into the sphingolipid-cholesterol 
complex in the Golgi. Protein interaction with the rafts can be ensured by different 
mechanisms: glycosylphosphatidylinositol (GPI)-anchored proteins have two saturated 
fatty acyl chains, membrane associated proteins are lipid modified, for transmembrane 
proteins transmembrane domains, in the case of intracellular proteins special lipid-
binding domains (e.g. pleckstrin homology-PH, C2) or acylation (palmitoylation, 
myristoylation, isoprenylation) provide raft associating capability. (23, 28) 
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Figure III. Structure of the lipid rafts 
Lipid components of the plasma membrane can be divided to three groups: sphingolipids, 
glycerophospholipids and sterols. Sphingolipids can be distinguished based on their head groups: 
sphingomyelin contains a phosphocholin, glycosphingolipids a carbohydrate group. Sphingolipids localise to 
the exoplasmic leaflet. Glycerophospholipids are found in both leaflets, but some of them (like phosphatidil 
inositol) are restricted to the cytoplasmic leaflet. Cholesterol fills the interspaces formed in between the 
sphingolipid and phospholipid chains. Protein interaction can be ensured by saturated fatty acyl chains 
(GPI-anchored proteins), transmembrane domains (transmembrane proteins), lipid-binding domains or 
acylation (intracellular proteins). 
 
 
2.2. S-acylation  
Lipid modification of proteins may occur co-translationally like N-terminal myristoylation 
or post-translationally like C-terminal prenylation of cytoplasmic proteins and 
palmitoylation of integral and peripheral membrane proteins (by the membrane 
associated palmitoyl acyltransferase (PAT)). Fatty acids are esterified to the free thiol of 
membrane-proximal cysteines. Post-translational lipid modification may occur by adding 
various fatty acids: e.g. stearic, oleic, arachidonic acid. The importance of S-acylation in 
T-cell signalling can be demonstrated by the row of S-acylated key signalling proteins: 
CD4, CD8β, the Src family kinases Fyn and Lck, Ras, the transmembrane adaptor 
proteins LAT, PAG (phosphoprotein associated with glycosphingolipid enriched 
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microdomains), LIME (Lck-interacting membrane protein) and NTAL (non-T-cell 
activation linker). In the case of CD8, palmitoylation was shown to be necessary for co-
receptor function since this modification enables it to associate with the lipid rafts and 
thereby recruit its binding partner Lck to the site of activation (29, 30). Lck has also to be 
palmitoylated in order for this interaction to occur. Both Lck and Fyn are primarily 
myristoylated on their amino-terminal glycin through a stable amide bond, but for stable 
membrane localization and lipid raft association they must be dually acylated. The 
position of the 16-carbon fatty acid palmitate and the charge of surrounding amino acids 
influence the protein distribution. For Lck it has been shown that a lack of palmitoylation 
due to mutations of Cys-3 and Cys-5 not only decreases its affinity for membrane 
localization but also makes it biologically inactive (31). From studies dealing with the 
relevance of palmitoylation sites it is known that the membrane proximal cysteines are 
more crucial than the distal ones for lipid raft targeting of Fyn (Cys-3), Lck (Cys-3) and 
LAT (Cys-26). In the case of Fyn the half-life of palmitoylation was also studied and was 
shown to be 1,5-2 hours while 8 hours were measured for the polypeptide backbone. 
This indicates that palmitoylation is a reversible modification and most probably plays a 
role in the regulation of membrane targeting. (S-acylation reviewed in (32)). Indeed, 50% 
of Fyn was found to be non-palmitoylated and localised to intracellular membranes and 
non-raft fractions in a mouse fibroblast cell line (33). The transmembrane adaptor protein 
LAT is palmitoylated at Cys-26 and Cys-29. Palmitoylation is essential for the targeting 
of LAT to the lipid rafts and for its tyrosine phosphorylation (34). As proper localization of 
LAT is required for efficient signalling and T-cell activation (35) one can conclude that S-
acylation is crucial for T-cell function. Note that one aim of this study is to investigate the 
role of palmitoylation in PAG function.  
 Inhibition of S-acylation by fatty acids or their analogues (e.g. 2-bromopalmitate) 
interferes with the raft localization of lipid modified proteins and T-cell activation. 
Inhibitors of palmitoylation influence Lck activity thereby suppressing signal transduction 
from the TCR. Polyunsaturated fatty acids (PUFAs) interfere with raft integrity by 
replacing saturated fatty acid residues in sphingolipids (36) and they were also shown to 
inhibit S-acylation. This gives a possible explanation for why the PUFAs are successful 
in immunosuppression when applied against inflammatory diseases like rheumatoid 
arthritis and Crohn´s disease (37).  
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2.3. Lipid rafts or DRMs? 
It has long been known that under certain conditions some membrane components are 
not solubilised by detergents. GPI-anchored proteins were shown to be resistant to 
Triton-X100 and lipid rafts were identified as detergent insoluble membrane domains. 
Incorrectly, rafts also called glycosphingolipid-enriched microdomains (GEMs) and 
detergent-resistant membranes (DRMs) appeared as synonyms in the literature. The 
main difference between these structures is that DRMs can be obtained at 4°C, but not 
at 37°C. Detergent resistance means that incomplete solubilisation occurs and large 
membrane fragments remain instead of micelle formation even at high detergent 
concentrations. One should not forget the observations that different detergents (Triton-
X100, Lubrol, Brij) revealed different “rafts”. DRM association of a protein does not mean 
raft localisation and vice versa. DRMs are evoked only after detergent treatment and 
they do not necessarily correspond to any pre-existing membrane structure (reviewed in 
(38)). Heerklotz gives us a very strict conclusion in his paper that summarises all the 
critics against associations between DRMs and rafts: “detergent resistant membranes 
should not be assumed to resemble biological rafts in size, structure and composition or 
even existence” (39). 
 
2.4. Enigmas surrounding the lipid rafts 
During the past few years “raftology” became a field full of controversial studies and 
discussions about the existence and properties of membrane domains. Due to the wide 
range of methods and technical limitations, the size, protein composition, appearance 
and function of lipid microdomains still remains obscure and the subject of debate. One 
has to be critical with the results obtained from biochemical approaches as they may 
reveal artefacts. Detergent solubilisations are usually carried out at 4°C. This non-
physiological temperature may alter the lipid organisation. As mentioned already (see 
section 2.3.) detergent resistance does not necessarily correlate with raft association of 
a protein but this does not mean that we should forget about detergents. In contrast to 
Triton-X-100, Brij 98 (polyoxyethylene) was found to preserve the composition and the 
protein interactions in the resistant membrane fractions. In contrast to other detergents 
(28) Brij 98 did not induce the appearance of non-plasma-membrane proteins (nuclear, 
ribosomal etc.) in DRM fractions. Importantly the same DRMs were isolated at 37°C with 
Brij 98 and with detergent free methods (40, 41). The difference in protein composition 
detected by various detergents can be also explained by the structure of the rafts. It was 
suggested that rafts may have a core which is resistant to strong detergents, like Triton-
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X-100 (contains ‘typical’ raft proteins, like LAT). On the other hand the peripheral region 
is more sensitive and gets dissolved by strong detergents and is preserved by Brij 98 
and Brij 58 (contains ‘atypical’ proteins CD45, MHC) (36). Another biochemical approach 
to study rafts is cholesterol depletion with cyclodextrins or synthesis inhibitors. But, since 
cholesterol is essential for the proper function of the cells, its depletion can cause 
complex effects: alteration of the membrane permeability, calcium dependent responses, 
ERK signalling and was shown to induce domain formation within the plasma membrane 
(28). Thus results obtained with this method may be misleading.  
The most reliable approaches are those, which observe living cells without 
manipulating them. However, it soon turned out that the resolution and sensitivity of light 
microscopes was not sufficient to detect the membrane rafts. New techniques were 
developed with increasing sophistication in order to gain more precise insight into the 
structure and dynamics of plasma membrane microdomains. The first direct visualisation 
of liquid ordered (lo) domains in living cells was obtained using Laurdan staining of 
macrophages by two-photon microscopy (42). Laurdan is a fluorescence probe with a 
red shifted profile when higher local hydration is detected in the membrane, and with a 
blue shift when low hydration is detected. Laurdan staining of living neutrophils also 
verified the existence of gel phase lipid rafts, as the lamellipodia (leading edge) of the 
intact cells contained blue shifted regions that spatially corresponded to ganglioside 
(e.g.GM3 lipid raft marker) enriched domains and was sensitive to cholesterol depletion 
(43). Recently another dye, the di-4-ANEPPDHQ has been applied to visualise lo phases 
at the plasma membrane. Fluorescent life time imaging (FLIM) together with this dye 
even detected varying levels of ordered phases (44). 
Fluorescence resonance energy transfer (FRET) is a widely used method to 
study the proximity of two proteins. Although it has high resolution (1-10nm between the 
donor and acceptor) it has provided mixed results. In some cases the raft markers 
showed random distribution (45), in others co-clustering was observed (46). Inefficient 
FRET may be caused by various physical factors (e.g. steric constraints between the 
donor and acceptor), which are independent of the observed biological system. 
Therefore the absence of evidence is not evidence of absence. For a long time, rafts 
were identified only at the outer leaflet of the plasma membrane. The first direct support 
for rafts in the inner leaflet was obtained by FRET analysis of S-acylated proteins (46). 
Biophysical approaches enabled researchers to observe membrane structure and 
components not only spatially but also temporally. Electron-paramagnetic-resonance 
spectroscopy highlighted that rafts are very dynamic structures. The exchange rate of 
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raft components between the rafts and their environment is on a submillisecond scale 
(47). Diffusion also contributes to the constant renewal of microdomain components. 
Photonic force microscopy and single fluorophore tracking are useful methods to follow 
the diffusion and dynamics of single proteins within the membrane (48). Nevertheless, 
fluorescence correlation spectroscopy seems to be the most powerful technique for 
diffusion analysis thanks to its high temporal resolution and accuracy (40). Despite 
technical problems researchers have produced a large amount of evidence for the 
existence of lipid rafts and the current view is that they are small (1-10nm, (36, 47, 49)), 
highly dynamic structures. In unstimulated cells the life time of small, unstable rafts is on 
the scale of milliseconds, while following ligand binding, the oligomerised GPI-anchored 
receptor molecules form stabilized rafts with lifetime of few minutes (50). Subczynski et 
al. suggested that the stabilized rafts promote forming of larger, temporal rafts which 
serve as signalling modules and include the inner leaflet of the plasma membrane (50). 
One should take in consideration the possibility that membrane associated proteins may 
also have organiser function. Maybe the lipid components serve only as platforms for the 
protein-protein interactions (51, 52) (T. Harder, M.J. Bijlmaker personal discussion). A 
recent paper (53) shows, what was already predicted by Munro (28), that protein-protein 
interactions and not detergent insolubility are responsible for assembly of signalling 
complexes.  
 
2.5. Lipid rafts and the TCR signalling 
In the majority of cells the lipid bilayer is continuously renewed. Phospholipids at the 
inner leaflet are hydrolysed by phospholipases and resynthetized by other enzymes. The 
products of hydrolysis (IP3, DAG, arachidonic acid) play a role in signalling processes 
and in regulating cellular functions. The decrease in the phosphatidylinositol 
concentration serves as an important signal for actin binding proteins and for those 
proteins possessing lipid binding domains e.g. PH and C2 domains through which they 
associate with the membrane lipids (54). 
 The TCR/CD3 complex was thought to be excluded from lipid rafts in resting 
cells. Horejsi (36) and others (55) speculated about the existence of two-step T-cell 
signalling in which two types of lipid rafts are involved. One set would preassociate with 
the TCR and may serve as a source of kinases necessary for signal initiation. The other 
would translocate to the aggregated TCR from cytoplasmic stores upon stimulation and 
could be involved in signal amplification. Recently it was shown that 10-20% of 
TCR/CD3 constitutively associates with a subset of lipid rafts which becomes the site of 
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signal initiation upon stimulation (40). This subset also contains CD4/8, Lck and CD45. 
Upon activation, the TCR complex is highly enriched in lipid microdomains (40). Raft 
association of Lck is ensured by myristoylation at Gly2 and palmitoylation at Cys3 and 
Cys5 (56). Additionally both CD4 and CD8 are palmitoylated which is necessary not only 
for their lipid raft association, but also for their efficient co-receptor function, and for 
association with Lck (57). The membrane phosphatase, CD45 positively regulates Lck 
activity. It was shown to be excluded from the rafts, but there are also groups, which 
could detect it inside the microdomains (58). The contradiction regarding the localisation 
of the TCR and CD45 in lipid rafts may emerge from different technical approaches. As 
mentioned already in section 2.4. lipid raft preparation with Brij 98 at physiological 
temperature preserves the interactions that are sensitive to stronger detergents. 
Therefore, studies using Triton-X-100 would not see raft association of the TCR/CD3 
complex and CD45. (The regulatory role of kinases and phosphatases is discussed in 
section 3.). Beside the Src kinases and co-receptors, adaptor proteins (LAT, PAG, 
NTAL, LIME) are also present in lipid rafts of resting cells (36). The cytoplasmic kinase 
Csk (C-terminal Src kinase) is recruited by PAG and its presence in proximity to the Src 
kinases may contribute to setting the threshold for TCR activation (59, 60). Upon TCR 
stimulation, Csk is released. PAG serves also as an anchor for the rafts via binding to 
EBP-50 (ezrin-radixin-moezin binding phosphoprotein of 50kDa) and thereby to ezrin-
radixin-moezin proteins and through them to actin (61, 62). (For more details about 
structure and function of adaptor proteins see section 4.). Werlen and Palmer (8) have 
suggested the term TCR signalosome for the complex that contains all elements 
necessary for signal initiation. It is enriched in cholesterol and sphingolipids and is highly 
dynamic. In the resting state, only weak associations occur among the signalosome 
members (40). Based upon the structural studies of the TCR/CD3 complex it has been 
speculated that upon stimulation, in addition to horizontal movements, vertical 
displacement between modules also occurs: transmembrane helices of CD3εγ and 
CD3εδ move up-and downward relative to one another and the TCRαβ chains. The 
horizontal movements lead to aggregation of lipid signalosomes that bring their protein 
components to the TCR signalosome. As fourth dimension one can consider the highly 
dynamic temporal feature of these changes (8). These multidimensional changes lead to 
expansion of the TCR signalosome and formation of scaffolds, like LAT/Grb2/SOS, 
LAT/GADS/SLP-76/Itk/Vav/PLCγ1, and SLP-76/Nck/PAK/WASP. These signalling 
pathways are discussed in sections 1.2. and 1.3. 
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2.6. Further roles of lipid rafts  
 
2.6.1. Costimulation and cytoskeletal rearrangement 
The importance of costimulation via CD28 was discussed in section 1.3. Are the 
membrane microdomains involved in this function? Several papers have shown that 
upon costimulation lipid rafts are mobilised, move from the cytoplasmic stores to the cell 
surface and take part in immunological synapse (IS) formation (63, 64). Lipid raft 
accumulation at the IS is dependent upon Vav-1, Rac, WASP, the SLP-76/Nck/Fyn/PAK 
complex and other molecules. Association of rafts with the actin cytoskeleton can be 
mediated by the adaptor protein PAG via the ezrin-radixin-moesin protein family and also 
by the PIP2/WASP/Arp2/3 complex. The actin-raft interaction may contribute to 
maintaining the resting state without stimulation. The reason and cause of the movement 
inhibition is still not clear: either the actin filaments anchor the rafts thereby inhibiting 
their aggregation at the plasma membrane or the rafts themselves inhibit the cytoskeletal 
rearrangements which would lead to receptor aggregation and signalling initiation. (36) 
 
2.6.2. Curing via lipid rafts 
Given that lipid rafts play a crucial role in T-cell signalling and they are involved in 
pathogenic attack against immune cells, they may be potential therapeutical targets. As 
mentioned already in section 2.2, polyunsaturated fatty acids are used clinically as 
immunosuppressants. Their effect can be explained by the observation that they disrupt 
the structure of lipid rafts (65). However, it is not only PUFAs that are able to modify the 
lipid composition of the inner leaflet of the rafts. Glucocorticoids are widely used steroids 
with immunosuppressive and anti-inflammatory effect. Recently they have been reported 
to inhibit T-cell activation by selectively altering the lipid raft localisation of Src kinases 
and LAT (66). 
 
2.6.3. Role of lipid rafts in other immune cells 
The importance of lipid rafts is not restricted to T-cells. They play a key role in NK and 
mast cell activation and in regulating B cell responses. They are also involved in the 
spatial organisation of peptide-MHCII complexes on the APC surface, this way ensuring 
the optimal arrangement for recognition by the T-cell. (36, 48)  
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3. Regulation of lymphocyte activation by kinases and phosphatases 
Maintaining T-cells in the resting state is an active process that requires equilibrium 
between protein tyrosine phosphatases (PTP) and protein tyrosine kinases (PTK). The 
balance of these enzymes resembles the harmony of yin and yang. Imbalance between 
PTPs and PTKs has pathological consequences in the form of autoimmunity, 
immunodeficiency and malignancy.  
 The subcellular localisation, activity and substrates of the PTPs and PTKs 
change during development and depend upon the activation status of the T-cell (67). As 
mentioned in section 1.2., several different kinase families take part in proximal (Src, 
Syk, Tec kinases) and distal (e.g. serine/threonine kinases, MAP kinases) TCR 
signalling. Here I shall focus on the proximal signalling events and upon Src family 
kinases (SFKs) in particular, as they are more relevant to the topic of this thesis. 
 
3.1. Src family kinases 
The Src family of tyrosine kinases (SFKs) include 11 members, of which 4 are expressed 
in T-cells: Lck, Fyn, Yes and Src (68). SFKs are present in all metazoan cells and are 
involved not only in antigen receptor induced signalling but also in growth factor, 
cytokine and adhesion signalling (69). SFKs possess a conserved structure consisting of 
a myristoylated N-terminal segment (SH4 domain, which is responsible for membrane 
targeting), an SH3 and SH2 domain (for protein-protein interactions), a linker region, a 
tyrosine kinase domain (SH1, possessing the enzymatic activity) and a short C-terminal 
tail with regulatory properties. The kinase is held in an inactive state by intramolecular 
interactions between the SH3 domain and the linker region and the SH2 domain and the 
C-terminal inhibitory tyrosine. These interactions can be competed out only by specific 
binding partners excluding the possibility of autophosphorylation that would lead to 
unregulated T-cell activation. How SFKs recognise their substrates is not known. The 
SH2 and SH3 domains have been suggested to play role in it either by directing the 
binding partner to the kinase domain or by ensuring spatial proximity (68, 69).  
 The SH4 domain is followed by a unique region, which has a role specific to 
each kinase. In Lck this region mediates its association with the cytoplasmic tail of 
CD4/8, in Fyn it may be responsible for interaction with the TCR. Beside the structural 
and post-translational modification similarities, initial experiments showed a common 
substrate panel for these two kinases. However, this view was changed by the results 
obtained from Lck deficient cell lines and knock out mice. It is now clear that Lck is the 
kinase responsible for initiating the TCR signalling cascade, but it is dispensable for 
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CD3-induced stimulation (70, 71), for the latter Fyn was shown to be crucial (72). 
Following TCR engagement Lck not only phosphorylates the ITAMs of TCRζ chains and 
CD3 but also ZAP-70, LAT and PLCγ. Targets of Fyn are the adaptor protein PAG, Pyk2 
(proline-rich tyrosine kinase 2) and it mediates formation of the Fyn/SLP-76/ADAP 
complex (14). In resting cells 75-95% of Lck localises in the non-raft membrane fraction 
while the majority of Fyn (98%) is detected within the lipid rafts (73). It is still unclear how 
Lck becomes activated but it is known that upon stimulation Lck translocates to the lipid 
rafts to mediate Fyn activation (73, 74). Brdičková et al (75) offers a nice model in which 
Fyn is phosphorylated and thereby activated by LIME-bound Lck. LIME is a raft-
associated adaptor protein that upon phosphorylation by activated Lck binds both Csk 
and Lck itself. Csk phosphorylates the inhibitory tyrosine of Lck but since the SH2 
domain is bound to LIME the closed conformation cannot be formed. This way the 
phospho-tyrosine remains free and is a potential binding site for an SH2 domain 
containing protein, which happens to be Fyn.  
 
3.2. Regulation of Src family kinases 
Many of the SFKs were identified as cellular oncogenes. They were found to contribute 
to the metastatic spread of carcinoma cells (76) and to be implicated in breast, colon and 
pancreatic cancers (Src), in malignant melanoma (Yes) and in acute lymphocytic 
leukaemias (Lck) (77, 78). These highlight the importance of a multilevel regulation of 
these crucial but also potential oncogenic kinases.  
 The kinase activity is regulated by tyrosine phosphorylation. It is believed that 
the activatory tyrosine (Y-394 in Lck and Y-418 in Fyn) within the activation loop of the 
kinase domain becomes phosphorylated by autophosphorylation (79). The C-terminal 
inhibitory tyrosine (Y-505 in Lck and Y-529 in Fyn) is phosphorylated by Csk (80), a 
distant relative of Src kinases (40% sequence identity) with different substrate specificity 
and regulation. Structurally Csk differs from SFKs in that it does not have an N-terminal 
lipid anchoring domain, an activation loop tyrosine or C-terminal inhibitory tyrosine (81). 
For proper function of Csk, both of its noncatalitic (SH2 and SH3) domains are important. 
Probably these are not only required for membrane targeting via binding to a membrane 
associated adaptor protein (PAG in resting, G3BP in activated cells, see details in 
section 4.1.2.) but they may help the enzyme to take the optimal shape for kinase activity 
(82). The recognition of the substrate tyrosine probably requires complex interactions 
dependent on the three-dimensional structure of both proteins (81) and involves the 
substrate docking site (SRSRRF) of Csk (83). Csk associates with the phosphatase PEP 
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(PEST enriched PTP) via its SH3 domain so that PEP is recruited to the plasma 
membrane together with Csk, where it can dephosphorylate its target proteins, Lck and 
Fyn at their activatory tyrosine. By tonic repression of Lck, Csk sets a threshold for TCR 
signalling and avoids hyperactivity (79). Csk is regulated by PKA and cAMP both in a 
spatial and enzymatic manner. Phosphorylation of its S-364 by PKA increases 2-4 fold 
the activity of Csk (84). The question, how PKA can regulate Csk when it is dissociated 
from lipid rafts following TCR triggering was answered by Vang et al (85). It is cAMP that 
stimulates targeting of Csk to the rafts where it is further activated via binding to PAG 
and by PKA. The phosphotranspherase activity of PKA-phosphorylated and PAG-bound 
Csk is 6-8 fold higher than that of cytosolic, unphosphorylated Csk. The indispensable 
role of Csk as a negative regulator of Src kinases is underlined by the fact that lack of 
Csk is incompatible with life (86). As a crucial negative regulator of Src kinases Csk 
could be a potential target in cancer therapy. It was shown that up-regulation of Csk 
function suppresses the metastatic potential of colon cancer cells (87). 
 CD45 is the phosphatase that opposes the function of Csk by 
dephosphorylating the C-terminal tyrosine of SFKs. This leads to a primed conformation 
that can be readily activated. CD45 is able to dephosphorylate the activatory tyrosines 
as well, but less efficiently. This dual function is regulated by spatial separation during 
TCR activation as CD45 is excluded from the immunological synapse and its effect on 
Src kinases remains net positive (67). 
 Protein tyrosine phosphatase α (PTPα), a widely expressed transmembrane 
enzyme is another member of the SFK regulatory network. It plays an important role in 
regulating tyrosine phosphorylation of Fyn and PAG in resting thymocytes: it negatively 
regulates the kinase activity of the raft-localised Fyn (88). The mechanism is similar to 
the one observed for CD45: both regulatory tyrosines of the Src kinases are 
dephosphorylated by these phosphatases with an overall negative effect. In the absence 
of PTPα, Fyn activity is increased and PAG is hyperphosphorylated (see also section 
4.1.3.) in resting thymocytes (88). 
 Src family kinases are not only regulated by kinases and phosphatases but also 
via subcellular localisation mediated by the lipid environment or by binding partners. The 
importance of S-acylation for localisation and proper function was already described in 
section 2.2. Here examples for the binding partners will be discussed. Lck is probably 
maintained outside of lipid rafts by CD4. Another candidate for this function is Cbl 
(Casitas B-lineage lymphoma) that was found to associate with Fyn and Lck via their 
SH3 domains in resting cells. This suggests that Cbl may express its inhibitory role in 
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two levels: in resting cells it depletes SFKs from the lipid rafts and in activated cells it 
mediates their degradation (89).  
 
3.3. Phosphatases  
Kinases are tightly regulated by phosphatases. Of the 95 human PTPs, 30 are 
expressed in T-cells. Some of them are transmembrane (e.g. CD45), others are 
cytoplasmic (e.g. PEP, PTP-PEST, SHP-1,2, LMPTP). The Csk associated 
phosphatases, PEP and PTP-PEST (phosphatase with PEST sequence) are related but 
have different roles. PEP regulates Src kinases (3.2.), while PTP-PEST substrates are 
the members of focal adhesion complex (see section 5.). SHP-1 (SH2 domain containing 
PTP) plays a negative regulatory role during thymic development by dephosphorylating 
ZAP-70. In contrast SHP-2 is a positive regulator as it facilitates the MAPK pathway. 
MAP kinases are very strictly regulated by a large number of phosphatases that control 
their activation spatially and temporally on levels of basal activity, peak activity and 
duration of activity.  
 
4. Adaptor proteins  
Adaptor proteins connect receptors with the intracellular signalling elements. As they 
possess modular domains and lack enzymatic activity they play a role in organising 
macromolecular complexes and recruiting cytoplasmic molecules to the plasma 
membrane (90, 91). According to their subcellular localisation one can distinguish two 
populations: cytoplasmic (e.g. SLP-76, GADS, ADAP, Cbl, Grb2) and transmembrane 
adaptor proteins (TRAPs). The latter can be further divided into lipid raft-associated 
(LAT, PAG, LIME, NTAL) and non-raft proteins (SIT-SHP2 interacting transmembrane 
adaptor protein, TRIM-T cell receptor interacting molecule, LAX-linker for activation of X 
cells) (11). The typical structural components of TRAPs are the tyrosine based motifs 
that are phosphorylated by Src or Syk family kinases and offer binding sites for SH2 
domain containing proteins, which are thereby localised to the right place at the right 
time. GEM-associated TRAPs are type III transmembrane proteins with a short 
extracellular and single transmembrane domain and a long cytoplasmic tail. They all 
contain a juxtamembrane positioned palmitoylation motif (CxxC). The non-GEM TRAPs 
are usually disulphide-linked homodimers, the exception being LAX. The cytoplasmic 
adaptor proteins are able to build up large protein complexes thanks to their diverse (e.g. 
SH2, SH3, PDZ, PH-pleckstrin homology) domains (11, 92). From functional point of 
view adaptor proteins may be positive, negative or bifunctional regulators (11, 93).  
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 The role of different adaptor proteins is discussed in the various chapters of this 
introduction (1.2., 1.3., 2.5., 2.6., 3.1., 5.) but since PAG is the focus of this thesis the 
next section shall be dedicated to it. 
 
4.1. PAG (phosphoprotein associated with GEMs)  
The protein was simultaneously identified by two groups. One described it as a member 
of the Fyn complex (94) and named it PAG (4). The other group found it as a Csk 
binding protein (Cbp) (59). 
 
4.1.1. Structure of PAG  
PAG/Cbp (hereafter referred to as PAG) is a 432aa protein in humans (429aa in mouse) 
with a short extracellular domain (16-18aa), a transmembrane domain (20aa) and a long 
cytoplasmic tail (387-396aa). The intracellular domain contains 10 tyrosine residues nine 
of which are potential target sequences for Src kinases (YxxL/I/V). Six of them show 
ITAM-like structure (YxxL/I/V(x)nYxxL/I/V) with values of n larger than in typical ITAMs. In 
addition there are 10 threonine, 12 serine residues and two proline rich regions that are 
potential binding sites for other signalling molecules. Some of the tyrosines and serines 
have been shown to be phosphorylated by mass spectrometry: Y-163, Y-181, Y-227, S-
229, S-239, Y-317, Y-341, Y-359, Y-387, Y-417 (http://www.phosphosite.org). Although 
the predicted molecular weight was 46,9 kDa, a retarded migration was observed on 
SDS-PAGE gel with an apparent size of 68-85 kDa. This anomaly can be explained by 
the acidic character of PAG and the level of tyrosine phosphorylation. In unstimulated 
Jurkat T-cells the suboptimally phosphorylated 68 kDa form could be detected while 
following pervanadate treatment a shift was observed to 80-85 kDa. (4, 59) 
 PAG has been localized to the plasma membrane and within that to the lipid rafts. 
It is believed that palmitoylation is responsible for the GEM targeting as it was shown 
that PAG is palmitoylated (4). However PUFA treatment that is known to interfere with 
lipid raft localisation of LAT and Lck, did not displace PAG (95). This may be due to an 
additional mechanism that links PAG to the GEMs i.e. a particular structure of the 
extracellular or transmembrane domain or a constitutively GEM associated yet 
unidentified binding partner of PAG (92). It has been suggested that together with other 
TRAPs, PAG may have a function in coupling the lipid microdomains in the outer leaflet 
with those in the inner leaflet (96, 97).  
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4.1.2. Function of PAG 
PAG is ubiquitously expressed, with the highest mRNA levels detected in peripheral 
blood leukocytes, heart, lung and placenta. Within PBLs it is strongly expressed in 
lymphocytes and monocytes and weakly in neutrophils and platelets (4). In most tissues, 
7 and 10kb transcripts were found, in heart and placenta an additional 3kb appeared and 
in brain only the 10kb form was detected. This suggests tissue-specific splicing (92). The 
broad expression of PAG is unique among the TRAPs and suggests that this protein has 
a general function in regulating cellular responses throughout the body. 
 Although pull down assays showed that PAG potentially binds a number of 
signalling molecules (e.g. Lck, Fyn, Vav, SLP-76, ZAP-70, Csk), in vivo only Fyn and 
Csk were associated (4, 60, 98). Csk binds Y-317 (Y-314 in the mouse) via its SH2 
domain. This interaction is necessary but not sufficient for Csk binding, indicating that 
other tyrosine(s), probably Y-299 (Lindquist, unpublished data), are also involved in it 
(99). Via targeting Csk to the lipid rafts, PAG actively takes part in increasing the 
activation threshold and in maintaining the resting state of the cell as Csk 
phosphorylates the negative regulatory tyrosine of Src kinases thereby keeping them in 
an inactive state. Accordingly, it was observed that overexpression of PAG in human 
peripheral T-cells (4) in Jurkat T-cell line (100) and also in a basophil leukaemia cell line 
(101) suppressed cellular responses mediated by Src kinases. Following T-cell activation 
PAG becomes dephosphorylated, Csk is released and Src kinases become activated. 
The activated Fyn in turn rephosphorylates PAG and it retargets Csk to the plasma 
membrane. This way the second function of Csk targeting realizes, namely that Csk 
down-regulates Src kinase activity and prevents the cell from overreacting the stimuli. 
The interaction with Fyn is non-covalent (4). Description of the exact mechanism 
of Fyn binding and localisation of the binding site is one aim of my work. Fyn was shown 
to be the kinase responsible for PAG phosphorylation but as the phosphorylation level of 
PAG was not completely reduced in the T-cells of Fyn-/- mice, other kinase(s) must also 
be involved (98). Davidson et al recently showed that the role of Fyn is not only PAG 
phosphorylation that enables recruitment of Csk, but it also transduces biochemical 
signals during TCR stimulation that lead to increased calcium flux. These opposing 
effects attribute PAG with a dual function what is reminiscent of other transmembrane 
adaptor proteins such as LAT, SIT and NTAL (99). 
 According to the current functional model (11, 15, 99) PAG recruits Csk (20-30% 
of total cellular Csk, (14)) to the proximity of Src kinases in resting cells, in this way 
ensuring their suppression. Upon stimulation PAG becomes dephosphorylated, PAG-
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Fyn association is rapidly lost and is followed by Csk release that allows  activation of 
the kinases that initiate the signalling cascade (99). As PAG is one of the Fyn substrates 
in turn it rephosphorylates PAG enabling it to bring Csk back to the lipid rafts. In this way 
the negative regulatory feed back loop closes and the signalling process is silenced. The 
question, where does Csk locate when it is released from PAG, was recently answered 
(102). G3BP binds Csk upon TCR stimulation in a similar time course as it dissociates 
from PAG. 
 
Figure IV. Model of PAG function 
PAG recruits Csk to the proximity of Src kinases (e.g. the PAG associated Fyn) in resting T-cells, in this 
way ensuring their suppression. Upon stimulation PAG becomes dephosphorylated by an unknown 
phosphatase and Csk is released, what allows the activation of Src kinases. The association with EBP-
50 is also resting cell specific. The activated Fyn rephosphorylates its substrate PAG, enabling it to 
bring Csk back to the lipid rafts. The negative regulatory feed back loop closes and the signalling 
process mediated by the Src kinases is silenced. 
 
Hermiston et al (67) predicted that eliminating PAG would have consequences on 
thymic development (similarly to the Csk-/- thymocytes, (103)) and could possibly lead to 
autoimmune diseases or lymphomas due to hyperactive Src kinases. However, detailed 
studies on mice having a disrupted PAG gene did not fulfil this prediction. 
Embryogenesis, thymic development, vital functions (growth, development, fertility), TCR 
induced proliferation, signalling events, humoral immune response and peripheral B-and 
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T-cell tolerance were all normal, resembling wt mice (104, 105). This makes the 
impression that the function of PAG in regulating Src kinases is so important that a 
compensatory mechanism developed in these mice, possibly provided by another 
adaptor protein with redundant functions. The potential candidates of Csk binding 
proteins are LIME, SIT, Dok-3, paxillin, FAK. Some of these translocate into the lipid 
rafts upon activation but others like SIT remain outside. It is still an open question 
whether Csk localisation to GEMs is altered in the absence of PAG. One group could 
clearly show reduced Csk levels within the lipid raft fractions (104) but the other found it 
comparable with the wild type cells (105). In the background of this inconsistency 
methodological differences in lipid raft isolation may be suspected such as iodixanol 
gradient vs. sucrose density gradient, eight vs. eleven fractions (104, 105). The finding 
that PAG can function both as a negative and as a positive regulator may also explain 
the lack of phenotype in PAG-deficient mice since removal of opposing signals may 
remain without net effect on cellular functions (99).  
PAG interacts with the adaptor protein EBP-50 that binds to the C-terminal TRL 
sequence of PAG via one of its PDZ (postsynaptic density/disc-large/ZO1) domains. The 
role of this interaction in anchoring rafts to the cytoskeleton was already mentioned in 
section 2.5. It was reported to negatively regulate immune synapse formation in 
unstimulated cells. Following stimulation the association is broken. The mechanism 
regulating the dynamics of this interaction is still unknown. (61, 62, 92) 
Recent work from our group describes a novel protein complex consisting of 
PAG, Fyn, Sam68 and RasGAP and suggests that this complex may play a role in 
development and maintenance of the anergic phenotype (an unresponsive state of T-
cells that can be provoked by a strong TCR mediated signal without costimulation) via 
inhibitory effects on proximal signalling (zeta chain- and LAT phosphorylation), block in 
Ras activation and block in cell cycle (Smida, submitted to Blood).  
 
4.1.3. Regulation of PAG 
As mentioned earlier the reversible protein phosphorylation is a widely employed 
mechanism for regulating various cellular functions, as protein localisation, assembly of 
protein complexes, enzyme activity and gene transcription. The phosphorylation of PAG 
appears to be controlled by Src kinases, primarily Fyn (4, 98). The phosphatase 
responsible for PAG dephosphorylation is still unknown. It would be important to identify 
it since dephosphorylation of PAG precedes and leads to Src kinase activation, which 
belongs to the very first steps of T-cell activation that is still veiled in mist. Possible 
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candidates are CD45 (100), SHP-2 (106), SHP-1, PTP-PEP, PTP-H1 (92) but none of 
them causes complete dephosphorylation. Davidson et al. have found that CD45 was 
involved in dephosphorylation of PAG upon TCR stimulation. Studies on CD45, PEP and 
SHP-1 deficient cells revealed that unlike CD45, PEP and SHP-1 were dispensable for 
dephosphorylation of PAG (100). As it has never been proved that CD45 directly acts on 
PAG, it can be speculated that CD45 regulates PAG phosphorylation via an indirect 
mechanism e.g. by inactivating Fyn via dephosphorylating its activatory tyrosine and 
thereby inhibiting phosphorylation of PAG (88, 100). In non-haematopoietic cells, where 
CD45 is not expressed, PAG still becomes dephosphorylated (100). Therefore it seems 
to be more correct to talk about PAG phosphatases instead of a phosphatase.  
PTPα was excluded to be a PAG phosphatase but from studies on PTPα 
deficient mice we know that it has an indirect effect on the phosphorylation status of 
PAG. In the absence of PTPα the kinase activity of Fyn is increased and in turn causes 
hyperphosphorylation of PAG. This effect was observed only in resting tymocytes of 
PTPα-/- cells indicating that PTPα is involved in regulation of tyrosine phosphorylation in 
thymocytes before TCR activation (88).  
 
4.1.4. PAG in non-T cells 
PAG functions as a negative regulator also in mast cells. Following aggregation of the 
FcεRI receptor, PAG becomes phosphorylated by the Src kinase Lyn, recruits Csk and in 
turn suppresses Lyn activity (101). The main difference in appearance of PAG in mast 
cells compared to T-cells is that it is not constitutively phosphorylated. The same was 
described for fibroblasts. To explain the difference in phosphorylation status of PAG in 
various cell types one has to think about the development and function of these cells. 
Peripheral T-cells have already undergone positive and negative selection and they 
constantly receive week stimulation in the periphery in order to stay alive. This keeps 
them in a kind of preactivated state in which the low level of activated Src kinases is 
sufficient to phosphorylate PAG and ensure that the presence of Csk prevents activation 
by low affinity MHC-TCR interactions (92). 
 In B cells Lyn has a dual function: via phosphorylating ITAMs it contributes to the 
initiation of BCR mediated signalling and by phosphorylating the ITIMs (inhibitory motifs) 
it can activate inhibitory molecules. In these cells the role of PAG is still not clear. Via 
Csk recruitment it may potentially inhibit both functions of Lyn that could lead either to 
down-regulation of B cell signalling or to temporal suppression of the inhibitory signals 
(15, 107).  
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 The first study showing a connection between PAG and a pathogen agent was 
published recently. Bovine T-and B-cells infected with the intracellular parasite Theileria 
parva, behaved as invasive tumours. As this kind of transformation is not connected with 
genomic alterations, it can be reverted by drug treatment. In infected cells, the 
expression of PAG was down-regulated and the lack of Csk in the plasma membrane 
resulted in increased Hck (haematopoietic-cell kinase) activity and proliferation. 
Following drug treatment the amount of PAG and Csk markedly increased at the plasma 
membrane and suppressed the oncogenic effect of the hyperactive kinase (108). In my 
opinion the fact that a pathogen evolutionary developed a mechanism to target PAG 
shows that PAG is an important actor in the cellular theatre and contributes to the fate of 
the cell. The fact that there was no observable phenotype in PAG-/- mice does not mean 
that PAG is unimportant, in contrary its function has to be ensured by redundant 
molecule(s) to avoid uncontrolled processes that could have fatal consequences for the 
whole organism.  
 
4.2. Perspectives for clinical application 
TRAPs were found to be useful markers in hematopathology as their expression can be 
connected to different cell types and therefore lymphomas of different origin. PAG, LAT 
and SIT are expressed both in T- and B-cells, LIME and TRIM are T-cell specific and 
NTAL is typical for B cells. Accordingly LIME and TRIM were found to be associated with 
T-cell lymphomas and LAT was the best marker for peripheral T-cell lymphoma. NTAL 
was the only TRAP expressed in hairy-cell leukaemia and in lymphocyte predominant 
Hodgkin disease. It was a clear marker together with PAG for follicle center lymphoma. 
NTAL, PAG and SIT showed complementary patterns of expression in B-cell 
lymphomas. SIT could be used as a marker for chronic lymphocytic leukaemia and 
mantle-cell lymphoma while it is not expressed in follicle-center lymphoma (109). PAG 
was earlier shown to be expressed in germinal centers of lymphoid follicules, but not in 
mantle cell lymphoma what may reflect role in regulation of proliferation and 
differentiation of germinal center B-cells. PAG could be a suitable positive marker for 
follicular lymphoma (together with NTAL) and a negative marker for mantle-cell 
lymphoma (110). 
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5. SDF-1 induced migration  
In the fight against pathogens lymphocyte migration plays a crucial role. For effective 
immune response naive T-cells have to be mobilised from the lymphoid tissues to the 
sites of antigen exposure. The induction of an immune response is mediated by the 
continuous migration of naive T-cells through the secondary lymphoid organs in 
response to chemoattractant gradients provided by chemokines (111). The chemokine 
superfamily of small, secreted proteins can be divided into four groups based on their N-
terminal cysteine motif: CXC (α), CC (β), C (γ) and CX3C (δ). Chemokine receptors are 
members of the seven transmembrane domain G protein coupled receptor family. The 
receptors CXCR1-5 bind CXC chemokines. CXCR4 was described in 1996 as a co-
receptor playing role in HIV-infection and therefore became the focus of many research 
fields. It is expressed on wide range of cells, including lymphocytes. In T-cells it can be 
found predominantly on unstimulated, naive cell population. It has a single ligand, the 
widely expressed stromal cell-derived factor 1 (SDF-1, also called CXCL12), that exists 
as two splicing forms: SDF-1α and SDF-1β. The mRNA of SDF-1α is more abundant 
than SDF-1β. They differ in amino acid sequence by the presence of additional 4 amino 
acids at the C-terminus of SDF-1β (112). CXCR4 and SDF-1 were found to be important 
not only for the homing of T-cells and recruitment to the sites of inflammation but also for 
haematopoiesis, organogenesis, vascularisation and embryogenesis (113). Therefore it 
is not surprising that disruption of either the SDF-1 or CXCR4 gene is lethal in mice 
(114). 
Several groups have shown that chemokine receptors localise to the lipid rafts 
after stimulation (115, 116). Like in the case of participants in TCR signalling there is still 
a debate about the raft-association, but it appears that the reasons for this are the same 
as described in section 2.4, namely the different methodological approaches. As shown 
for CD3 and CD28, cross-linking of chemokine receptors also causes lipid raft 
aggregation and polarisation that is critical for processes such as migration (116). 
Knowing that chemokine receptors possess large transmembrane domains it is not 
surprising that upon cholesterol depletion CXCR4 undergoes conformational changes 
and SDF-1 binding is altered (117). CXCR4 is present in the non-raft region of the 
plasma membrane, but from yet unknown reasons SDF-1 is able to bind only to the raft 
associated pool of the receptor. It was suggested that in circulating T-cells, CXCR4 is 
mainly outside of the lipid rafts and following an activation signal (e.g.: CD4 
engagement) it becomes recruited to the rafts (116, 117) where SDF-1 can induce the 
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signalling pathway leading to chemotaxis. Rafts are probably acting as spatial organisers 
and amplification centres during chemotaxis (51). 
The crucial role of Src kinases in the migration of haematopoietic cells is well 
established within the literature. A physical interaction between Lck and CD4 and the 
kinase activity of Lck are both required for the SDF-1 induced chemotaxis (118). Lck 
associates with a number of proteins that play a role in actin cytoskeleton reorganisation, 
which is necessary for the migratory response: Vav, PKCθ, Itk (118, 119), PI3K (120), c-
Cbl (121, 122). In T-cells not only Lck but also Fyn is implicated in this process (121, 
122). ZAP-70, which is a substrate for Lck, was also found to be involved in migration 
signalling (123), playing role in Erk activation (124). ZAP-70 may provide a link to PI3K, 
which showed increased tyrosine phosphorylation upon SDF-1 stimulation (125). Studies 
using special inhibitors established the crucial role of PI3K in migration signalling that is 
manifested via its effectors. One of PI3K target proteins is the serine/threonine kinase 
PKB (protein kinase B), which takes part in regulation of the transcription factor NFκB 
(120).  
The ability of Csk to inhibit the chemotactic response (118) further highlights the 
role of Src kinases. Fyn may have a regulatory role in migration via association with the 
tyrosine phosphatase SHP-2 and phosphorylation of the adaptor molecule Cbl. SHP-2 
interacts with CXCR4 and forms a complex with SHIP (SH2-containing inisitol 
phosphatase), Cbl, PI3K and Fyn. While SHIP down-regulates migration, SHP-2 has a 
positive regulatory function. Cbl may have a dual function: as an adaptor protein it 
associates with SHP-2, Vav and PI3K thereby taking part in positive regulation. On the 
other hand, as a ubiquitin ligase it is involved in degradation of various receptors and 
tyrosine kinases (121). The fourth protein that negatively regulates migration is p62Dok-
1 (downstream of tyrosine kinase). As Src kinases play role in phosphorylation and 
activation of this protein, it provides a feed back loop which down-regulates the migratory 
signals (126). CD45 is the second phosphatase (beside SHIP) involved in regulation. It 
activates Src kinases (via dephosphorylating their negative regulatory tyrosine) and the 
components of the focal adhesion complex (127).  
Proteins of the focal adhesion complex (Pyk2, FAK, Crk, p130Cas, paxillin) are 
stimulated by SDF-1 (125, 126). Pyk2 (proline-rich tyrosine kinase 2) is critical for 
signalling through G protein coupled receptors. It associates with ZAP-70 and Vav and 
participates in the activation of the MAPK pathway (126). As chemokine receptors are G-
protein coupled, G protein subunits also take part in the migratory response of 
lymphocytes. GTPases (e.g. Rac, Rho, Rap1) that play a role in actin cytoskeleton 
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reorganisation and cell polarisation are activated by the G protein subunits β and γ (120, 
128). 
There is evidence for interplay between the TCR and CXCR4 mediated signalling 
pathways. It has been shown that proteins that play an important role in proximal TCR 
signalling (e.g. Src kinases, ZAP-70, PLCγ (125)) are activated upon SDF-1 stimulation 
and are involved in chemokine receptor signalling (129). A recent paper (130) has 
identified with the help of FRET analysis and coimmunoprecipitation that there is a 
physical interaction between CXCR4 and the TCR. They also show that upon SDF-1 
stimulation the CXCR4 mediated signalling pathway exploits the constitutively tyrosine 
phosphorylated pool of TCR-ZAP70 complexes leading to Ras activation and prolonged 
ERK activation. Earlier studies have revealed the existence of low amounts of 
constitutively associated TCR and ZAP-70 (131). Via depleting key TCR signalling 
proteins, SDF-1 may regulate the threshold of T-cell activation (129). Once this threshold 
was overcome, a stable contact forms between the APC and the T-cell, which would not 
occur without inhibiting the cells´ mobility. The calcium release that is induced via TCR 
stimulation leads to phosphorylation of the T-cell specific myosin MyH9 (nonmuscle 
myosin heavy chain IIA), which was shown to be the motor of T-cell crawling. 
Phosphorylation down-regulates its motor function and this leads to the “stop migration 
signal”, despite the high calcium concentration, that would otherwise activate calcium-
dependent proteins, like myosin (132, 133). TCR stimulation also blocks SDF-1 induced 
chemotaxis via PKC-dependent internalisation of CXCR4 receptor (129). 
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Figure V. Proteins involved in migration signalling 
Some of the proteins and their interactions that take part in SDF-1 induced signalling pathways are shown in 
this figure. Actin cytoskeleton reorganisation and cell polarisation are mediated in a Src kinase (via Vav and 
Itk)- and G protein dependent manner (via GTPases). The Src kinases (Fyn and Lck) are both complex 
forming units and activators of other proteins. Members of the focal adhesion complex are distinguished with a 
fence pattern, while squared lines indicate a complex formed by both positive and negative regulators: Fyn, 
SHP-2, PI3K, SHIP, Cbl. Red colour indicates inhibitory role (Cbl has a dual function). The pattern of bricks 
represents lipid rafts.  
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RESULTS I 
 
1. How much does palmitoylation contribute to the function of PAG? 
 
Like all lipid raft associated transmembrane adaptor proteins, PAG also contains a 
dicysteine motif (CSSC) within its cytoplasmic domain that is located in a juxtamembrane 
position and is conserved among species (Figure 1.1.).  
 
 <--extracellular-><--transmembrane---><------cytoplasmic---+   
  
           1 MGPAGSLLGSGQMQ--ITLWGSLAAVAIFFVITFLIFLCSSCDREKKPRQHSGDHENLMN human 
           1 ......V.S.....MQMV.........M..L....VL...T................P.. mouse 
           1 ......A.S.....MQMV.........M..L.....L.......D...........S... rat 
  
Figure 1.1. Alignment of the first 60 amino acids of PAG 
Dots represent conserved amino acids, hyphens indicate gaps in the alignment.  
 
This motif is a potential target for S-acylation and indeed, PAG has been shown to be S-
acylated by 3[H]palmitate-labeling. This lipid modification is thought to be responsible for 
the GEM targeting of the protein (4) based upon results obtained with LAT mutants (34), 
where palmitoylation was shown to be indispensable for targeting LAT to the GEMs. It 
has also been shown that lipid raft targeting of LAT is required for its function and for 
proper T-cell signalling (34, 35). However, the importance of GEM localisation was 
recently brought into question, as the non-raft associated LAX/LAT chimera was able to 
restore T-cell function in LAT deficient cells (134). LAX has been described as an 
adaptor protein which is excluded from the GEMs (135). The distribution within the 
plasma membrane of both, LAX and the LAX/LAT chimera was studied using sucrose 
gradient centrifugation. The apparent contradiction between the two studies (34, 134) 
dealing with the role of lipid rafts in LAT function may be solved with the newly emerging 
results from the lab of Vaclav Horejsi (Horejsi V. Signalling roles of lipid rafts and raft 
associated adapter proteins. 16th European Congress of Immunology, Paris, France, 2006, Book 
of Abstracts p. 41). Using a gel filtration method, they detected LAX and LAX/LAT in the 
same fractions as LAT, which explains why the chimera could restore the function of the 
wt LAT. The palmitoylation mutant of LAT was excluded from the raft fractions which is in 
line with the previous results (34). Horejsi proposed a new view of lipid rafts suggesting 
that two kinds of rafts exist: light and heavy rafts. The latter consist less of lipids and 
more of proteins than the light rafts and therefore do not float upon sucrose gradient 
centrifugation. The reason why LAX and the LAX/LAT chimera were detected in the non-
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raft fractions may be that they are associated with the heavy rafts, possibly as part of a 
larger protein complex. 
However, the question of whether the palmitoylation of PAG is essential for its 
localisation and function remained open. Therefore we have investigated both the 
subcellular distribution and the function of the PAG palmitoylation mutant.  
 
1.1. Expression and localisation of the palmitoylation mutant 
To study the effect of the CSSC → ASSA mutation (hereafter referred to as CxxC) it was 
necessary to incorporate an epitope tag into both the wild type and the mutant PAG 
construct to distinguish them from the endogenous protein upon transfection since PAG-
deficient cell lines do not exist at present. Therefore an 8 amino acid peptide, Flag-tag 
(DYKDDDDK) was fused to the carboxyl terminus of PAG. Using Western blot and 
microscopic approaches the expression of the fusion proteins was found to be unaltered. 
Our aim was to generate stably transfected Jurkat T-cell lines, however we did not 
succeed. Therefore Jurkat E-6 T-cells (clone Kab14) were transiently transfected with 
the PAG constructs in all experiments performed. The expression levels of both the Flag-
tagged wild type PAG (hereafter referred to as wt PAG) and the mutant protein (CxxC) 
were comparable (Figure 1.2.A). Lysates from human peripheral blood T-cells and Jurkat 
T-cells were probed for endogenous PAG. The expression pattern of endogenous PAG 
did not show any difference compared to the overexpressed PAG as both molecular 
weight forms (at 72 and 60 kDa) were detected and showed similar distribution to the 
overexpressed constructs (Figure 1.2.B). Since both the wild type and CxxC mutant 
proteins are expressed in two forms, the difference in size is not due to the post-
translational lipid modification.  
 
A B  
w
t P
A
G
 
T-
ce
lls
 
Ju
rk
at
 
ve
ct
or
 
C
xx
C
 
 
 
-72 
-55 
-72 
 
-55 
 
Figure 1.2. Expression of wt PAG and CxxC mutant 
A) Whole cell lysates from Jurkat T-cells transfected with either vector alone, wt 
PAG or CxxC mutant. The expression was visualised with rabbit-anti-Flag 
antibody. B) Whole cell lysates from human peripheral T-cells and Jurkat T-cells 
stained with mouse-anti-PAG antibody. 
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 The subcellular localisation of the mutant PAG was investigated by 
immunofluorescence microscopy. Figure 1.3.A shows that neither the inclusion of an 
epitope tag nor mutation of the palmitoylation motif affected PAG expression and its 
plasma membrane localisation. The specificity of anti-Flag staining is demonstrated by 
the negative control where cells transfected with vector alone show no staining. Flag-
tagged TRIM served as a positive control, as a transmembrane adaptor protein having a 
staining pattern that is typical for a membrane associated protein.  
 Although the ring shaped staining observed under the fluorescence light 
microscope was identical for endogenous PAG, the Flag-tagged constructs and TRIM, 
and seemed to suggest plasma membrane localisation of the palmitoylation mutant, a 
confocal microscopy approach that enabled us to analyse the cells with higher resolution 
was used to strengthen these data. Jurkat T-cells transfected with either the wild type or 
mutant PAG were co-stained for the Flag-tag and a membrane associated protein which 
was either endogenous TRIM or Fyn (Figure 1.3.B). The staining pattern and the 
colocalisation with typical plasma membrane associated proteins is a clear proof of 
membrane localisation for the mutant PAG and excludes the possibility of a 
submembrane position. Anti-Flag staining also shows some intracellular staining that 
supports the idea of ER-association mentioned above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CxxC wt PAG Endogenous PAG 
 
 vector TRIM  
 
Figure 1.3.A Membrane localisation of wt PAG and the CxxC mutant 
Jurkat T-cells transfected with the indicated constructs were stained for the Flag tag with 
mouse-anti-Flag antibody, and visualised with fluorescence microscope. Endogenous PAG was 
stained with mouse-anti-PAG antibody. 
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Figure 1.3.B Colocalisation of wt and CxxC mutant PAG with TRIM and Fyn 
Jurkat T-cells transfected with wild type and mutant PAG were co-stained for Flag-tag (rabbit-anti-
Flag/donkey-anti-rabbit-FITC) and either for the transmembrane adaptor protein TRIM (mouse-anti-
TRIM/goat-anti-mouse-Texas red) or the plasma membrane anchored Fyn (mouse-anti-Fyn/goat-
anti-mouse-Texas red) and visualised with confocal microscope. 
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1.2. The effect of palmitoylation mutation upon GEM localisation 
Once the membrane localisation of the mutant PAG was established, the next step was 
to determine whether it was still capable of being targeted to the GEMs. Lysates from 
transfected Jurkat T-cells were fractionated upon sucrose density gradients and 
subsequently 9 fractions were collected. Since CD59 is a glycosylphosphatidylinositol-
anchored protein it is considered to be a proper GEM marker (4, 50), therefore a dot blot 
with a sample from each fraction was stained with anti-CD59 antibody. Based upon the 
CD59 staining we conclude that fractions 2-4 represent the GEMs (Figure 1.4.A) and the 
heavy fractions 8-9 are considered as non-GEM fractions.  
 
1 2 3 5 4 6 7 8 9 
vector 
wt PAG 
CxxC 
 
 
 
 
 
Figure 1.4.A Staining for GEM fractions upon sucrose density gradient fractionation 
1µl from each fraction was dotted on a nitrocellulose filter and was stained with mouse-anti-CD59 antibody. 
 
The distribution analysis of wt and the mutant PAG shows that while wt PAG 
preferentially localises to the GEMs, the CxxC mutant is more abundant in the non-GEM 
fractions. The 60 kDa form of PAG was always found in the heavy fractions (Figure 
1.4.B).  
 
1 2 3 5 4 6 7 8 9 
wt PAG 
CxxC 
 
 
 
 
 
Figure 1.4.B Distribution of wt and CxxC PAG among the membrane fractions 
Rabbit-anti-Flag staining.  
 
Since a recent paper pointed out that acylation alone was not sufficient for the 
complete targeting of LAT to the lipid rafts (136), it is not surprising that the palmitoylated 
wt PAG is not exclusively raft localized. The idea of Shogomori et al. is that S-acylation 
alone is insufficient to overcome the large energetic cost of packing transmembrane 
helices into rafts. Constitutively raft associated proteins (e.g. GPI-anchored proteins or 
certain adaptor proteins) probably serve as anchors via protein-protein interactions for 
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those proteins which have less affinity for lipid raft binding (136). This could explain the 
remaining GEM localization of the mutant PAG. One candidate for such interaction could 
be EBP-50, which possesses two PDZ domains and could thereby potentially bind two 
PAG molecules. A dimer forming in this way, consisting of one endogenous and one 
mutant PAG could recruit the mutant into the lipid rafts. Another candidate protein that 
may support PAG recruitment to the lipid rafts is Fyn. Dual acylation (i.e. myristoylation, 
palmitoylation) of the Src family kinases also attributes them with an anchoring role. 
Based upon the observation that the enrichment of CD4 in the GEMs is not only 
palmitoylation-dependent, but also requires Lck association (57), Fyn could play a similar 
role in anchoring PAG as Lck does in recruiting CD4. 
Pooling together the GEM- (2-4) and the non-GEM (8-9) fractions highlighted the 
differences and also made it possible to compare the samples on the same gel excluding 
the possibility that variations in electrophoresis or blotting were responsible for the 
differences observed. Staining for LAT, another lipid raft associated protein, shows that 
the integrity of GEMs remained intact and that the overexpression of the PAG constructs 
did not alter the distribution of other GEM localised proteins. Whole cell lysates prepared 
from the same transfectants prior to GEM preparation were included as controls for 
protein expression. (Figure 1.4.C) 
 
 
 
                                            
                                   
                                  
                   
 
 
 
Figure 1.4.C GEM localisation of wt and CxxC PAG 
Pooled fractions 2-4 and 8-9 represent GEM- and non-GEM fractions, 
respectively. Rabbit-anti-Flag staining shows the localisation of the PAG 
constructs, rabbit-anti-LAT staining indicates intact GEM architecture. As a 
control for expression levels 1x106 cells from each transfection were lysed and 
loaded together with the fractions. 
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1.3. Is the palmitoylation mutant phosphorylated? 
PAG is one of the most abundant phosphoproteins in unstimulated T-cells (4). Therefore, 
we looked to see whether the non-raft associated PAG mutant becomes tyrosine 
phosphorylated. PAG was immunoprecipitated using Flag M2 affinity gel. Since the 
presence of the antibody chains in immunoprecipitates (IPs), particularly the heavy chain 
may interfere with detecting proteins of similar size (~55 kDa) on Western blot the 
captured constructs were eluted from the Flag-agarose with Flag peptide. Figure 1.5. 
clearly shows that the equally expressed wt and CxxC PAG were phosphorylated to the 
same extent. One can also observe that the lower molecular weight form of PAG is less 
phosphorylated, suggesting that the 60 kDa form of PAG differs from the 72 kDa form in 
the extent of phosphorylation. 
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Figure 1.5. Both wt and CxxC mutant PAG become phosphorylated 
Flag immunoprecipitates from transfected Jurkat T-cells were immunoblotted with 
rabbit-anti-Flag and mouse-anti-phosphotyrosine-HRP [pY20] antibodies. 
 
1.4. Which kinase phosphorylates PAG? 
Studies on peripheral T-cells and thymocytes from Fyn-/- mice have clearly demonstrated 
that Fyn is predominantly responsible for the phosphorylation of PAG in resting T-cells 
(98). However, PAG phosphorylation was not completely inhibited in Fyn-deficient cells 
indicating that other kinases may be involved in PAG phosphorylation (98). The kinase 
activity of Fyn and Lck show different localisation within the plasma membrane of both 
resting and stimulated T-cells. Lck kinase activity was mainly detected outside of the lipid 
rafts, while Fyn showed a much higher activity in the rafts than in non-raft fractions, but 
the amount of Fyn is also much higher in GEMs (14, 98). This means that the relative 
kinase activity of individual Fyn molecules may be equal throughout the plasma 
membrane or even higher in the non-raft fractions and the reason why less Fyn activity is 
detected outside of the rafts might be that less Fyn localises to this membrane fraction. 
From this point of view, it is worth to speculate that the few Fyn molecules residing in the 
non-raft fraction may have a comparable enzymatic activity to the raft-associated Fyn 
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population and could be responsible for the phosphorylation of the PAG palmitoylation 
mutant. On the other hand, one has to take into consideration that the low amount of Fyn 
may be inefficient in phosphorylating PAG and that another kinase might also be 
involved. Indeed, Brdicka et al. showed that both Fyn and Lck are capable of 
phosphorylating PAG (4) and in mast cells Lyn plays this role (137).  
 To determine which kinase is responsible for the phosphorylation of the 
palmitoylation mutant, Jurkat T-cells transfected with vector, wt PAG and CxxC PAG 
were treated with the Src kinase inhibitor PP2 (pyrazolopyrimidin) prior to lysis. PP2 was 
also included in the lysis buffer to prevent post-lysis phosphorylation. Anti-Flag IPs were 
probed with anti-Flag antibody to ensure that equal amounts of the PAG constructs were 
immunoprecipitated and subsequently the blots were stained for phosphotyrosine. Figure 
1.6. shows that despite the higher protein amounts in the PP2 treated 
immunoprecipitates, the tyrosine phosphorylation was markedly reduced, indicating a 
Src kinase dependency for the phosphorylation of both wt and the CxxC mutant of PAG.  
 
  vector wt PAG CxxC
_ _ _ PP2 + + +  
-72 
-55 
-72 
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Figure 1.6.  Phosphorylation of wt and CxxC PAG is PP2 sensitive 
Flag immunoprecipitates from transfected Jurkat T-cells treated with PP2 (+) or left 
untreated (-) were immunoblotted with rabbit-anti-Flag and mouse-anti-
phosphotyrosine [4G10] antibodies.  
  
 To get further insight into the mechanism of CxxC PAG phosphorylation, anti-
Flag immunoprecipitates were tested for Fyn binding. Elution of the PAG constructs from 
the agarose with a Flag peptide was especially useful in these studies since the heavy 
chain of immunoprecipitating antibody would interfere with the Fyn staining because of 
the similarity of the molecular weights of these two proteins (55 and 59 kDa, 
respectively). To avoid that the lower molecular weight band of the overexpressed PAG 
construct overlaps with the band representing Fyn, the immunoblots were first probed for 
Fyn. Whole cell lysates were also included to show the expression level of the proteins 
of interest. Figure 1.7. shows that in addition to comparable levels of expression, Fyn 
was found to associate with both wt PAG and the CxxC mutants. 
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Figure 1.7. Both wt and CxxC PAG associate with Fyn 
Jurkat T-cells were transfected with the indicated constructs and the 
immunoblot was stained with rabbit-anti-Flag and mouse-anti-Fyn 
antibodies. 
 
 Since Lck was also shown to be capable of phosphorylating PAG (4), the 
possibility exists that it could also contribute to the phosphorylation of the mutant PAG, 
which mainly localises outside of the lipid rafts where Lck is much more abundant than 
Fyn. To test this, Lck deficient Jurkat T-cells (JCam 1.6) were transfected either with one 
of the PAG constructs or the vector alone. One set of transfectants was cotransfected 
with Lck as a control to show that a possible difference in phosphorylation is due to lack 
of Lck and does not originate from the use of a different cell line. The expression level of 
Lck was checked in whole cell lysates. The lowest panel on Figure 1.8. shows three Lck 
species: the band at 45 kDa represents the defective Lck (Δexon7) from the 
mutagenesis, which does not have kinase activity. The upper bands (at 70-75 kDa) 
represent the kinase active Lck transcribed from the transfected CFP containing 
construct (the CFP that is inserted between the SH4 and SH3 domains causes the 
increase in size of Lck). The appearance as a double band is probably due to 
phosphorylation. Flag IPs were probed for Lck association and with anti-
phosphotyrosine. Although the phosphorylation of both PAG constructs required the 
presence of Lck no direct association of Lck to PAG was detected (Figure 1.8.). 
However, the lack of association does not exclude the possibility that the 
phosphorylation was mediated by Lck. Although it is more likely that the two pools of 
Fyn, the lipid raft associated and the non-raft pool, are responsible for phosphorylation of 
PAG wherever it localizes. The indispensable role of Lck is most likely in the activation of 
Fyn (14, 73) that in turn phosphorylates PAG. Experiments employing siRNA against 
Fyn in wt Jurkat cells would be required to clarify this issue. 
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Figure 1.8. Lck plays a role in phosphorylation of PAG  
JCam 1.6 cells were transfected with the indicated constructs. The immunoblot with 
Flag IPs was probed with rabbit-anti-Flag, mouse-anti-phosphotyrosine [4G10] and 
mouse-anti-Lck antibodies. Whole cell lysates were probed with mouse-anti-Lck to 
control the expression level of Lck. 
 
 
1.5. Does the palmitoylation mutant recruit Csk and EBP50?  
Having shown that the palmitoylation mutant of PAG is capable of binding Fyn and is 
phosphorylated to the same extent as the wt protein, we next asked whether it is also 
capable of recruiting Csk to the plasma membrane, since the interaction between PAG 
and Csk is phospho-dependent (4, 59, 138). Flag immunoprecipitates probed for Csk 
clearly show that the mutant is indeed capable of binding Csk (Figure 1.9.). 
 The third binding partner of PAG is EBP-50, a cytoplasmic adaptor protein that 
binds to the C-terminal TRL motif of PAG via one of its PDZ domains in resting T-cells. 
Upon TCR stimulation this association is lost (62). We wished to test whether this 
interaction occurs between the mutant PAG and EBP-50 as well, but as we could not 
detect EBP-50 association with the wt PAG we suspected that the C-terminal Flag-tag 
may interfere with EBP-50 binding. Therefore, we took the advantage of the N-terminally 
tagged PAG construct (N-PAG) that was newly designed during the course of my other 
project (generation of this construct is described in Results II.). First, we checked 
whether this construct localises to the plasma membrane (see in ResultsII/2.4.) and 
associates with its binding partners in a similar manner to the C-terminally tagged PAG 
(Figure 1.10.A), then we generated the N-terminally tagged palmitoylation mutant by site 
directed mutagenesis (CxxCN). The N-terminally tagged PAG constructs were not as 
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efficiently expressed as the C-terminally tagged ones, therefore the lower molecular 
weight form (~60kDa) of PAG was detected only in experiments where higher cell 
numbers were used (e.g. GEM preparation, Results II/Figure 2.8.). Despite the lower 
expression level and altered lipid raft localisation (Results II/4.) we found these 
constructs suitable for EBP-50 interaction studies. As Figure 1.10.B demonstrates, EBP-
50 was present not only in Flag-IPs from wt N-PAG (as expected), but it was also 
associated with the palmitoylation mutant. Because of the high amount of EBP-50 
expressed in Jurkat T-cells and the sensitivity of the antibody, it was necessary to cut the 
blot and probe the lysates and Flag-IPs with different antibody dilutions (1:10.000 vs. 
1:1000, respectively). 
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Figure 1.9. Wt PAG and the CxxC mutant equally bind Csk  
Jurkat T-cells were transfected with the indicated constructs and the 
immunoblot was stained with rabbit-anti-Flag and rabbit-anti-Csk antibodies. 
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Figure 1.10. Interaction with EBP-50 is not altered 
Jurkat T-cells transfected with the indicated constructs were lysed and immunoprecipitated with 
anti-Flag antibody. A) Expression, phosphorylation level, Csk and Fyn binding ability of N-PAG is 
demonstrated by rabbit-anti-Flag, anti-phosphotyrosine [pY20-HRP], rabbit-anti-Csk and rabbit-
anti-Fyn staining of Flag immunoprecipitates. B) Lysates and IPs were probed for Flag expression 
with rabbit antibody. Rabbit-anti-EBP-50 staining was carried out on cut blots with 1:10.000 and 
1:1000 antibody dilutions for lysates and IPs, respectively. 
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 1.6. The CxxC mutant enhances specific TCR proximal events 
PAG is a negative regulator of T-cell signalling as it down-regulates Src kinase activity 
by recruiting Csk to the lipid rafts. Since Src kinase activation is one of the first events 
upon TCR stimulation, we carried out a detailed analysis of proximal signalling. To 
monitor changes in the activity of the Src kinases, we stained the lysates obtained from 
vector, wt PAG or CxxC PAG transfected Jurkat T-cells, with Lck phospho-specific 
antibodies (Figure 1.11.A). The phosphorylation of the Lck activatory tyrosine (Y-394) is 
increased both in the basal state and upon stimulation due to CxxC mutant 
overexpression while no significant differences were observed in the phosphorylation of  
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Figure 1.11.A In contrast with the inhibitory role of wt PAG, overexpression of the 
CxxC mutant has a positive effect on activation of several proximal signalling elements 
Jurkat T-cells transfected with the indicated constructs were either left unstimulated (-) or were stimulated 
(+) via CD3 with OKT3 antibody for 2min. Lysates were stained against Lck, ZAP-70, PLCγ and Erk with 
total or phospho-specific rabbit antibodies (note, the anti-pY-418 antibody recognises the activatory tyrosine 
of Src, as well as Fyn and Lck – see Figure 1.12.).The blot was probed for total phosphotyrosine with 
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mouse-anti-pY [4G10]. Rabbit-anti-Flag staining monitors the expression level of PAG constructs. Mouse-
anti-actin staining serves as loading control. Cross-reactivity was avoided by stripping the blot. 
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Figure 1.11.B CxxC PAG overexpression increases phosphorylation of Lck, PLCγ and Erk 
The graphs represent the ratio of phospho-specific staining to total protein amounts for Lck, ZAP-70 and PLCγ. 
Phospho-Erk staining is quantified to actin. Note, that the increase in phosphorylation of Y-418 is 46% and 76% in 
CxxC overexpressing cells compared to the wt PAG in unstimulated and stimulated samples, respectively. The 
mean intensity of phospho-Erk staining shows 30% increase as an effect of the palmitoylation mutant. To 
calculate the mean values for Erk phosphorylation the values of Erk1 and Erk2 were added, divided with 2 and the 
result of this operation was divided with the values of actin signal. 
 
the inhibitory (pY-505) tyrosine (Figure 1.11.B). Phospho-tyrosine staining revealed 
differences in phosphorylation of four proteins migrating at 170kDa, 150kDa, 70kDa and 
36kDa. Phosphorylation of these proteins was inhibited by wt PAG and was enhanced 
upon overexpression of the CxxC mutant. Based upon the size of these proteins, we 
probed the blots further for two possible candidates, ZAP-70 (70kDa) and PLCγ 
(150kDa). Quantification of the signal intensities presented as the ratio of phospho-
specific staining to total protein further highlight the observed differences for PLCγ 
(Figure 1.11.B). Using a phospho-specific antibody for ZAP-70, the increase in 
phosphorylation caused by the CxxC PAG compared to the vector control that was seen 
in the total pTyr blot disappeared. One explanation for this is the presence of multiple 
tyrosine phosphorylation sites within ZAP-70, which would be measured by anti-pY 
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probing but not by a single site-specific antibody. Phospho-Erk staining is a widely 
accepted indicator of more distal signalling. Quantification of pErk amounts to actin, 
showed 30% increase in CxxC mutant compared to the vector control and the wt PAG 
overexpressing cells (Figure 1.11.B). 
 
409  GLARLIEDNEYTARQGAKFPI      Src 
407  ..........Y..........      Fyn 
384  ..........Y...E......     Lck 
 
Figure 1.12. Sequence alignment of human Src, Fyn and Lck 
The pY-418 Src antibody was raised against pY-419 in Src. Due to the obvious 
similarities in the amino acid sequence of the Src kinases the antibody 
recognizes the activatory tyrosine of Fyn (Y-417) and Lck (Y-394) as well. The 
target tyrosine is highlighted with underlining. Dots represent conserved amino 
acids. 
 
 Seeing the enhanced PLCγ phosphorylation induced by the overexpression of the 
palmitoylation mutant one might expect to detect an increase in intracellular Ca  flux. 
However, as 
2+
Figure 1.13. shows we could not detect enhancement in CxxC PAG 
overexpressing cells, while wt PAG caused a moderate decrease. One can speculate 
that the signal measured in vector transfected cells is the maximum response and 
overexpression of the palmitoylation mutant could not increase it more. As a positive 
control the maximal level of calcium mobilisation was induced with ionomycin, an 
ionophore that is capable of elevating the intracellular calcium concentration.  
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Figure 1.13. CxxC PAG does not increase Ca2+ flux 
After recording the baseline activity, anti-CD3 [c305] was added (filled triangle) to the Jurkat T-
cells transfected with either vector alone (   ), wt PAG (   ) or CxxC PAG (   ). Addition of 
ionomycin is indicated by the white triangle.  
 
1.7. The effect on SDF-1 induced migration 
Since PAG regulates Src kinase activity, processes mediated by the Src kinases appear 
to be the best read-outs for the functional consequences of depleting PAG from the lipid 
rafts. In addition to TCR signalling, Src kinases play an essential role in T-cell migration 
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(118, 122) therefore we extended our functional analysis with migration assays. We have 
chosen SDF-1 for stimulation because it is known that its receptor, CXCR4 is lipid raft 
localised and the signalling pathway generated upon SDF-1 stimulation involves 
exclusively the raft fraction of the plasma membrane (51, 116, 117).  
Jurkat T-cells transfected either with wt PAG or the CxxC mutant were allowed to 
migrate through a polycarbonate membrane (5µm pore size) for four hours following the 
addition of the chemoattractant SDF-1 to the lower chamber of the transwells. As a 
negative control, cells from each transfection were also left unstimulated. This way we 
were able to take into account the spontaneous migratory activity of the cells that occurs 
without chemokine stimulation. Data obtained from six independent experiments 
demonstrate that while wt PAG mildly suppresses the migratory response, the 
palmitoylation mutant enhances it (Figure 1.14.). To exclude the possibility that the 
observed difference was due to altered cell surface expression of the chemokine 
receptor, the expression levels were measured by FACS. The profiles presented in 
Figure 1.15. demonstrate that the expression levels were comparable on the surface of 
vector and CxxC PAG transfected Jurkat T-cells. The wt PAG overexpressing cells show 
a somewhat higher expression level which further strengthens the phenotype in the 
sense that these cells showed a decrease in migratory response even though they were 
potentially more receptive to the stimulus. 
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Figure 1.14. CxxC PAG enhances SDF-1 induced migratory response 
SDF-1 induced migration of Jurkat T-cells transfected with the indicated constructs. The 
migration index shows the relative number of migrating cells compared to the 
unstimulated control. Statistical significance is defined as P < 0,05. The ∗  indicates 
P=0,01. 
 
 
 57
     
Figure 1.15. CXCR4 expression is not altered upon transfection 
Vector (   ), wt PAG (   ) and CxxC PAG (   ) transfected cells were extracellularly 
stained with mouse-anti-CXCR4/donkey-anti-mouse-FITC antibodies. Mean 
fluorescence intensity values (MFI) are: 30,3 for vector, 36,5 for wt PAG, and 31 for 
CxxC PAG. The grey curve (  ) demonstrates that the aspecific background 
fluorescence from the secondary antibody was very low (MFI: 4). 
 
 
1.7.1. SDF-1 induced calcium mobilisation 
Although there are no available studies on calcium mobilisation upon CXCR4 receptor 
stimulation in T-cells, there are data which indicate that in different lymphocytic cell lines 
SDF-1 induces a transient increase in the intracellular Ca  concentration 2+ (139). 
Therefore, we performed experiments with our PAG mutants where we measured Ca  
flux upon SDF stimulation. Our results indicate that Jurkat T-cells mobilize only moderate 
calcium amounts compared to other cell lines, such as SupT1 or MOLT-4 
2+
(139). 
However there is a clear difference between the Ca  flux generated by the CxxC PAG 
and wt PAG overexpressing cells. As a positive control the maximal level of calcium 
mobilisation was induced by ionomycin. (
2+
Figure 1.16.)  
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Figure 1.16. CxxC PAG slightly increases intracellular calcium flux 
upon SDF-1 stimulation compared to wt PAG 
After recording the baseline activity, SDF-1 was added (filled triangle) to the Jurkat T-
cells transfected with either vector alone (   ), wt PAG (   ) or CxxC PAG (   ). Addition of 
ionomycin is indicated by the white triangle. The inset box is enlargement of the Y-axis. 
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1.7.2. Proximal signalling upon SDF-1 stimulation 
As migration is a complex phenotype we also analysed the proximal signalling events 
upon SDF-1 stimulation. Src kinase activation was monitored by phospho-specific 
staining of the lysates acquired from SDF-1 stimulated Jurkat T-cells transfected with 
either of the PAG constructs or the vector alone. Overexpression of wt PAG strongly 
reduced the phosphorylation of the activatory tyrosine of Src kinases (note, the anti-pY-
418 antibody recognizes the activatory tyrosine of Src, as well as Fyn and Lck – see 
Figure 1.12.). The palmitoylation mutant overexpressing cells showed not only an 
increased and more sustained activity of the Src kinases upon stimulation, but also an 
enhancement of their basal activity (compare time 0 in Figure 1.17.A). Erk 
phosphorylation indicated that the cells were indeed stimulated. Quantification of pErk 
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Figure 1.17. Src kinase activation is enhanced by the CxxC mutant upon SDF-1 stimulation 
A) Jurkat T-cells transfected with the indicated constructs were stimulated with SDF-1 for the indicated times. 
Lysates were probed with rabbit-anti-pErk, rabbit-anti-Flag and mouse-anti-actin antibodies. The phosphorylation 
level of the Src kinases was visualized by rabbit-anti-pY-418 staining (the lower band is Lck, the upper band 
represents Fyn). Mouse-anti-Lck staining shows total Lck amounts (lower band). B) Quantification of total pErk 
staining to actin counted from the mean values. 
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indicates a small (20%) increase in phosphorylation of total Erk in the cells 
overexpressing the palmitoylation mutant (see the graphs in Figure 1.17.B). Flag staining 
demonstrates comparable expression levels of the constructs while actin staining serves 
as loading control. These results further support those from the migration assays. 
 
1.7.3. The effect of PAG downregulation on migration  
In order to further investigate the role of PAG in SDF-1 induced migration, we examined 
the effect of small interfering RNA (siRNA) of PAG on the migratory response. As  Figure 
1.18.A shows, PAG gene expression is strongly downregulated by the siRNA in Jurkat T-
cells. Reduction of PAG expression through siRNA clearly enhances the migratory 
response upon SDF-1 stimulation. It is noteworthy that the spontaneous migratory 
activity is also increased to a curtain extent by siRNA inhibition of PAG, however the 
difference is not significant (Figure 1.18.B). 
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Figure 1.18. PAG downregulation results in increased migratory response 
A) Lysates from Jurkat T-cells transfected either with vector control or PAG specific siRNA were 
probed with mouse-anti-PAG (MEM255) and mouse-anti-β-actin antibodies. B) Vector or siRNA 
transfected cells were loaded into transwells and either left without stimulation (-) or  stimulated 
with SDF-1 (+). The number of migrated cells was counted in the lower chamber of the 
transwells after 4 hours of incubation by flow cytometer for 1min. Statistical significance is 
counted from three independent experiments and is defined as P < 0,05. The ∗  indicates 
P=0,01. 
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The stimulatory effect of PAG specific siRNA on T-cell migration further highlights 
the negative regulatory role of PAG in SDF-1 mediated signalling pathways. The 
observation that downregulation of the endogenous PAG results in the same functional 
disorder as dislocation of PAG from the lipid rafts points on the importance of localisation 
in the regulation of proteins and cellular processes. 
 
1.8. Altered Csk distribution and its effects 
Although the palmitoylation mutant of PAG is still capable of recruiting Csk to the plasma 
membrane, it localises it to a different membrane fraction than wt PAG. In this way, the 
inhibition imposed by Csk over the Src kinases within the lipid rafts is released and 
should lead to an increased and more sustained activation of Fyn and Lck.  
To test this hypothesis, we reprobed the GEM fractions for Csk. While probing of 
whole lysates indicated that the levels of total Csk were equal between the transfectants, 
we found that the level of Csk within the GEMs was reduced to the level of vector 
transfected cells by over-expression of the CxxC mutant. Additionally, one can see that 
over-expression of the wild-type PAG increased Csk amounts within the GEM fractions 
(Figure 1.19.). Together these results suggest that the mechanism of action involves the 
redistribution of Csk within the cell. However, as PAG is capable of binding 20-30% of 
the total cellular Csk amount (14), the differences in PAG mediated Csk distribution are 
not detectable within non-GEM fractions where the bulk of Csk resides.  
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Figure 1.19. Distribution of Csk throughout the membrane fractions 
Sucrose density gradient fractions 2-4 (GEM), 5-7 and 8-9 (non-GEM) were pooled and 
immunoblotted with rabbit-anti-Csk antibody. Whole cell lysates from 1x106 cells, not exposed to 
the fractionation process, are showing equal Csk expression in all three transfectants. 
 
 
If our proposed mechanism of CxxC mutant PAG function is correct, then the 
altered distribution of Csk should also be reflected by changes in the phosphorylation of 
the activatory and inhibitory tyrosines of Src kinases within the GEM and non-GEM 
compartments. Therefore we reprobed the pooled fractions using phospho-specific 
antisera for the activatory tyrosine of Fyn (pY-418). Figure 1.20.A shows that there is 
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indeed an increase in the activatory tyrosine phosphorylation within the GEM fractions of 
cells expressing the palmitoylation mutant. To demonstrate this more clearly, graphs with 
the quantified data normalised to total Fyn amounts are presented  in Figure 1.20.B. 
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Figure 1.20.  Fyn Y-418 phosphorylation is enhanced within the GEMs of 
CxxC PAG overexpressing cells 
A) Rabbit-anti-pY-418 and mouse-anti-Fyn stainings of the pooled GEM fractions mirror the 
altered phosphorylation pattern of Fyn. The antibody against pY-418 recognises both Fyn 
and Lck. The upper band corresponds to Fyn. B) Quantification of pY-418 staining from two 
independent experiments. The bars represent the ratio of pTyr staining to total Fyn amount 
within GEM fractions. Statistical significance is defined as P < 0,05. The ∗  indicates P=0,04. 
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DISCUSSION I 
 
The aim of this project was to clarify the role of palmitoylation in the localisation and 
function of PAG. The questions we have propounded were similar to those addressed in 
studies of LAT, which have recently brought controversial results (34, 35, 134). LAT is 
one of the lipid raft associated transmembrane adaptor proteins and, as such, it 
possesses a dicysteine motif that was shown to be palmitoylated and play a role in 
targeting of the protein to the GEMs (34). As lipid raft localisation of LAT was shown to 
be required for its phosphorylation and the initiation of signalling pathways downstream 
of the TCR (35, 95) one could conclude that the palmitoylation of LAT is crucial for 
proper T-cell function. However, the newly published data on the LAX/LAT chimera (134) 
seemed to scramble the picture formed about LAT over the past decade. The attractive 
hypothesis concerning two types of lipid rafts (described in Results I.), i.e. light and 
heavy rafts (V. Horejsi) offers an explanation to the contradiction regarding the necessity 
of lipid raft association for the function of LAT. 
 Both the endogenous PAG and the overexpressed PAG constructs are 
expressed in two molecular weight forms: 72 and 60 kDa (Figure 1.2.). The 60 kDa form 
is characteristic also of the palmitoylation mutant meaning that the difference in size is 
not due to post-translational lipid modification. It is more likely that they differ in the 
extent of phosphorylation, as the 60 kDa form is less phosphorylated (Figure 1.5.). 
Based upon microscopy stainings (Figure 1.3.B) we propose that the smaller form does 
not localise at the plasma membrane but in the ER and/or cytoplasmic vesicles. GEM 
preparation strengthens this idea as the low molecular weight form does not associate 
with the lipid rafts (Figure 1.4.B). 
 Similarly to LAT, mutation at the palmitoylation site in PAG excluded the majority 
of the protein from the lipid rafts (Figure 1.4.B,C). Despite its dislocation, the mutant 
PAG was properly phosphorylated (Figure 1.5.), recruited Csk to the plasma membrane 
(Figure 1.9.) and bound EBP-50 (Figure 1.10.) to the same extent as wt PAG. The 
association with EBP-50 occurs via the C-terminal TRL motif and one of the PDZ 
domains of EBP-50 (61, 62). Due to the presence of a second PDZ domain, EBP-50 has 
the potential to support the formation of PAG dimers. Dimerisation between endogenous 
PAG and the overexpressed palmitoylation mutant could explain the presence of the 
small population detected within the GEMs in the absence of S-acylation. To test this 
idea, we have generated a mutation (T430A) in wt and CxxC PAG that was reported to 
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be unable to bind EBP-50. (62). The experiments with these mutants are currently 
ongoing in our laboratory. 
Although we did not observe a difference in the level of phosphorylation or in the 
binding of the associated proteins, we set out to test whether there is an effect upon 
signalling processes caused by the dislocation of the palmitoylation mutant from the lipid 
rafts. Following short term (2min) stimulation via CD3, we observed 46% enhancement 
in Lck basal activity that was further induced (up to 76%) by the palmitoylation mutant 
upon stimulation compared to the wt PAG overexpressing cells. Overexpression of the 
wild type protein results in an irreversible inhibition (4), which abrogates Lck activation 
even upon stimulation. This inhibitory effect is diminished when the palmitoylation mutant 
is overexpressed and a marked increase is detected in Lck autophosphorylation 
following CD3 stimulation. The strong decrease in tyrosine phosphorylation of ZAP-70 
and a milder inhibition in PLCγ activation in cells overexpressing wt PAG is in line with 
the literature (4, 100). The enhanced phosphorylation level of these proteins due to the 
CxxC mutant was also propagated to distal signalling events, like Erk phosphorylation 
(Figure 1.11.A,B). The marked effect upon PLCγ activation called for the next set of 
experiments, which measured intracellular Ca2+ flux in Jurkat T-cells overexpressing the 
PAG constructs. Wt PAG partially suppressed the release of calcium, which was 
expected from the proximal signalling data however, the palmitoylation mutant did not 
cause any change compared to the vector control (Figure 1.13.). Looking at the 
ionomycin induced calcium signal it is tempting to assume that the calcium response is 
already saturated upon stimulation and a potential positive effect (i.e. removal of a 
negative regulator) can not increase it further.  
As functional read-out we have applied migration assays since migration is a Src 
kinase mediated response (118, 122) and PAG is involved in the regulation of Src 
kinases via recruiting Csk. Our results clearly demonstrate that removal of PAG from the 
lipid rafts leads to an enhanced migratory response (Figure 1.14.). Whilst we have seen 
striking differences in Src kinase activation between wt PAG and the CxxC mutant 
overexpressing cells (Figure 1.17.A), the Ca2+ flux does not seem to be as much affected 
(Figure 1.16.). The Ca2+ response is initiated by IP3 that is generated upon PLC 
activation. It is still unclear whether the PLCs become activated via a Gα (140) or Gβγ 
(141) mediated pathway. Tyrosine phosphorylation of PLCγ is increased in a rapid and 
transient manner upon SDF-1 stimulation in a myeloid cell line (125). In addition to PLCγ, 
PLCβ was also found to be involved in the chemokine-induced responses. However, 
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data from neutrophils show that although PLCβ isoforms were activated by chemokines, 
they were not required for chemotaxis (142). The difference in the two read-outs, i.e. 
proximal signalling and Ca-flux measurement, may be that the pathways leading to Src 
kinase activation and to calcium mobilisation diverge. The slight increase in intracellular 
Ca2+ seen in the palmitoylation mutant overexpressing cells may be due to a cross-talk 
between these two pathways. This idea is supported also by the observed 20% increase 
in Erk phosphorylation. 
Altered distribution of Csk caused by the changes in lipid raft localisation of the 
mutant PAG was shown by staining for Csk in lipid raft fractions isolated from transfected 
Jurkat T-cells (Figure 1.19.). The consequences of Csk dislocation from the lipid rafts 
were reflected in the phosphorylation of the activatory tyrosine of Fyn (Figure 1.20.). 
PAG dislocation from the lipid rafts resulted in increased Src kinase activity within the 
rafts what is in concert with the SDF-1 induced proximal signalling data (Figure 1.17.A). 
 The results obtained with the siRNA of PAG (Figure 1.18.), namely that 
downregulation of PAG expression increased the migratory response of Jurkat T-cells, 
not only supported our proximal signalling and functional data generated by SDF-1 
stimulation but also further highlighted the importance of localisation in regulation of the 
signalling machinery and cellular functions. Dislocation from the lipid microdomains 
leads to the same phenotype as downregulation of PAG what clearly shows that lipid raft 
association is indispensable for PAG to fulfil its negative regulatory function.  
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RESULTS II 
 
2. Localisation of the Fyn binding site 
 
In addition to studying the role of palmitoylation in PAG function, we have been working 
on localising the Fyn binding motif within PAG. Although it has been previously shown 
that Fyn is the kinase responsible for PAG phosphorylation (4, 98), the site of interaction 
remained unknown. By identifying the Fyn binding site we hope to better understand how 
the kinase interacts with its target protein, and thereby study the functional 
consequences of Fyn-PAG association. 
 Our strategy was to generate truncation mutants to localise the region of 
interaction, thus arose the need for an N-terminally tagged PAG construct (here after 
referred to as N-PAG). We chose Flag as an epitope tag since we had good experience 
with it in our laboratory. 
 
2.1. Generation of N-terminally Flag-tagged PAG  
To ensure membrane targeting of the construct, we synthesized an oligonucleotide 
where the CD8 leader sequence was added to the Flag epitope and which had Aat II and 
Nco I restriction sites on its 5´ and 3´ ends, respectively (see the sequence in the 
Methods). The CD8-Flag sequence was ligated into the pGEM-5Zf (+) vector, which was 
previously linearised by Aat II/Nco I double digestion (see the strategy presented in 
Figure 2.1.). We have chosen this vector because of its relatively small size (3 kb) that 
unburdens the insertion of a small (98bp) oligonucleotide and because it had a 
multicloning site with Nco I and Not I restriction sites which were necessary to preserve 
the full length and original sequence of PAG during the ligation. Also, this vector is 
suitable for blue/white screening of the colonies that makes the cloning process more 
convenient. To prevent recircularisation of the plasmid without the insert, we alkaline-
phosphatase treated the linearised vector and phosphorylated the oligos to provide the 
phosphates on both ends of the insert which are indispensable to achieve ligation. 
Following restriction digest and alkaline phosphatase treatment, the vector was purified 
on a 1% agarose gel and extracted with the Nucleo Spin Extract Kit. The dimerised 
oligos were phosphorylated by polynucleotide kinase treatment and extracted from the 
protein contents of the reaction by phenol/chloroform/isoamylalcohol. The success of the 
ligation was tested by Nhe I digestion. Since the vector does not carry this restriction 
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site, linearisation can only be achieved by the presence of the insert (Figure 2.2.A). Aat II 
and Nco I digestions were necessary to check the integrity of the restriction sites that 
were required for further ligations (Figure 2.2.B). 
 
Figure 2.1. Strategy for N-terminally Flag-tagged PAG generation 
As a first step CD8-Flag was ligated into pGEM-5Zf vector using the Aat II-Nco I sites. PAG was then 
inserted at the Nco I-Not I site. The Flag-tagged PAG was excised from the pGEM vector and inserted 
into pEF-IRES using Sma I-Not I ligation. The Nhe I site within the CD8-Flag tag was used for screening 
the colonies. 
 
1 2 3 
 A 
3kb 
2kb 
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 B 
4kb 
3kb 
2kb 
1 2 3 1 2 3 
colony1 colony2 colony3 pGEM-5Zf 
1 2 3 1 2 3 
 
 
 
 
 
 
 
 
Figure 2.2. Screening for CD8-Flag-pGEM positive colonies 
A) Nhe I digestion of one colony: 1. Intact pGEM-5Zf vector, 2. Undigested plasmid isolated from a 
single colony, 3. Nhe I digestion. The arrow indicates the linearised plasmid. B) Aat II and Nco I 
digestion of the vector and three colonies. The restriction sites of colony 1 and 2 are damaged. 1. 
Intact vector, 2. Aat II digestion, 3. Nco I digestion. The marker is Hyperladder I. 
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Once we had the CD8-Flag oligonucleotide in the vector the next step was to 
ligate Nco I/Not I digested PAG to the 3´end of the CD8-Flag sequence (Nco I/Not I 
digested, alkaline phosphatase treated CD8-Flag/pGEM-5Zf). To screen positive 
colonies, a PCR reaction was designed in a way such that two PCR products (217bp 
and 371bp) would indicate a positive colony (Figure 2.3.).  
 
A  
Nco I Primer I 
217bp 
Primer III Primer II 
CD8-Flag PAG 
371bp 
 
 
 
 
 
 
B  
 
 
400bp 400bp 
250bp 
200bp 
 
200bp 
 
50bp 
primers  
 
Figure 2.3. PCR reaction for screening CD8-Flag-PAG positive colonies 
A) Schematic depiction of the primers and the expected products on CD8-Flag-PAG 
sequence. B) The result of the PCR reaction. The arrows point on the PCR products of 
expected size. The marker on the left side is Hyperladder I, on the right side Gene Ruler 50bp 
Ladder. 
 
Since the pGEM-5Zf vector is not compatible with mammalian cells, we had to 
transfer the CD8-Flag tagged PAG into an appropriate expression vector. Our choice 
was pEF-IRES, a mammalian expression vector which possessed the Not I restriction 
site. Since it lacked Aat II within the multicloning site we took the advantage of Sma I 
that enabled us to insert our DNA using a blunt-end ligation. The sticky ends of the CD8-
Flag-PAG insert and the vector (Sma I/Not I digested) were filled in by Klenow enzyme 
(DNA Polymerase I Large fragment). Following this reaction phosphorylation of the insert 
was not necessary, however alkaline phosphatase treatment of the vector was required. 
The success of ligation was checked by PCR. Not I digestion served to visualise the 
linearised plasmid. We used Nhe I digestion to check the orientation of the insert as 
blunt end ligation gives the possibility for ligation in two orientations. If the insert is in the 
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right orientation, digestion results in a small fragment that we cannot detect on a 1% 
agarose gel and a long fragment of 7,2 kb. The wrong orientation would lead to detection 
of a fragment of 1,5 kb size. The colony presented on Figure 2.4. carries the plasmid 
with the insert in the right orientation. The positivity of the colonies was verified by 
sequencing (carried out by GATC Biotech). 
 
1 2 3 1 2 3 
4kb 
8kb 
pEF-IRES colony 
7,2kb 
6kb 
1,5kb 
 
 
 
 
 
 
 
Figure 2.4. Testing of the CD8-Flag-PAG-pEF-IRES positive colonies 
1. intact plasmid, 2. Nhe I digestion, 3. Not I digestion. The linearised pEF-IRES is 
5.6kb, following ligation of the Flag-tagged PAG it is 7.2kb The marker is Hyperladder I. 
 
 
2.2. Generation of truncation mutants 
Once we had generated the N-terminally tagged PAG, we could then proceed with the 
generation of the truncation mutants. As Fyn association with PAG was shown to be 
phospho-independent (4), we therefore focused on the proline-rich regions within PAG 
as potential binding sites for the SH3 domain of Fyn. Like all Src kinases, Fyn possesses 
an SH2 and an SH3 domain, which are potentiated for protein-protein interactions. SH2 
domains recognise phosphoproteins (143), while SH3 domains are specialized for 
proline-rich sequences containing a core PxxP motif (144). The literature provides 
examples for interactions via both Src homology domains of Fyn (145, 146). Additionally 
we have taken into consideration the RxxK motif juxtaposed to the palmitoylation motif, 
since Fyn has been shown to associate with the adaptor molecule SAP (SLAM-
associated protein) via its SH3 domain and an RxxK motif in SAP (146). 
 The truncation mutants were generated by inserting STOP codons at the sites 
indicated in Figure 2.5. STOP4 lacks an unconventional proline-rich region (PRR) 
(PxxxP), STOP3 is missing the membrane distal PRR, STOP2 loses the membrane 
proximal PRR. STOP1 contains only the palmitoylation and the RxxK motifs with no 
tyrosines remaining in this sequence. The integrity of each construct was checked by 
sequencing.  
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Figure 2.5. Truncation mutants generated from N-PAG 
TM stands for transmembrane region. The green boxes label the Flag-tag, red stripes show the sites of 
STOP codon insertion, pink boxes label the palmitoylation site, and yellow boxes represent the RxxK motif. 
 
 
2.3. Expression of the truncation mutants 
The truncation mutants were tested for expression in HEK 293T cells (an embryonic 
kidney cell line) and in Jurkat T-cells. Lysates were prepared and loaded onto 12% 
ProSieve gels, which provide better resolution than the standard acrylamide:bis gel. To 
avoid loss of the smallest truncated protein by blotting through the membrane and to 
increase the efficiency of transfer, we chose PVDF (polyvinylidene difluoride) 
membranes for electroblotting. Figure 2.6. shows the expression pattern in HEK 293T 
cells, from which we could estimate the size of the truncated proteins. The predicted 
sizes were as much different as in the case of the full length PAG (4). The reason for this 
discrepancy may be due to phosphorylation (in unstimulated cells PAG is 
phosphorylated) and the acidic nature of the protein that together result in an anomalous 
binding of SDS and thus retarded migration during electrophoresis (4). The latter 
explanation is especially true for STOP1 that lacks all tyrosines, which are potential sites 
for phosphorylation. 
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 Size [kDa] 
protein predicted apparent 
STOP1 5,7 15 
STOP2 12,6 25 
STOP3 26 37 
STOP4 39,5 60 
N-PAG 47 72 
 
 
 
Figure 2.6. Expression of the truncated proteins in HEK 293T cells 
Rabbit-anti-Flag staining of cell lysates transfected with the indicated proteins. Protein size was 
predicted with the help of Compute pl/MW tool at http//:www.expasy.ch web site. 
 
2.4. Membrane localisation of the truncation mutants 
Jurkat T-cells transfected with the truncation mutants were stained for Flag and analysed 
by confocal microscopy. We chose the membrane localised CD29 (integrin β1 chain, 
VLA-4 β chain) protein as a membrane marker. The pattern of the individual stainings 
indicates that the occurrence in the plasma membrane is comparable for the mutants 
and CD29. Each mutant was capable of localising to the plasma membrane to similar 
extent as the full length N-terminally tagged PAG with the exception of STOP1. In the 
case of STOP1 and partially also in STOP2 we could observe vesicular localisation. 
Figure 2.7. demonstrates representative cells from each transfection. In some cells 
STOP1 showed membrane localisation, in others vesicular and submembrane position. 
This can be due to the lack of association with a possible membrane anchoring protein, 
failure in processing the truncated protein, unstable membrane localisation or fast 
degradation. As the number of cells which showed membrane localisation of STOP1 was 
variable among the experiments and in some cases membrane association was the 
typical appearance, we assumed that the physical condition of cells prior to transfection 
may affect the capability of processing this mutant. Considering the staining results from 
several experiments and observed cells we decided to continue our studies also with the 
shortest construct. 
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STOP1 
STOP2 
STOP3 
STOP4 
N-PAG 
CD29 Merge Flag 
 
Figure 2.7. The truncated proteins localise to the plasma membrane 
Jurkat T- cells transfected with the indicated constructs were stained with rabbit-anti-
Flag/donkey-anti-rabbit-FITC, mouse-anti-CD29/donkey-anti-mouse-Cy5 antibodies. 
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 2.6. Lipid raft association of the truncated mutants 
The importance of protein-protein interactions in the localisation of proteins to certain 
membrane fractions is more and more evident in the literature (28, 53). Filipp et al. has 
recently reported that the C-terminus of Lck is indispensable for the lipid raft association 
and thereby for its function as the Fyn activating kinase (Filipp et al., 16th European 
Congress of Immunology, Paris, France, 2006, Book of Abstracts p. 115, PB-1434). These 
observations drove us to check lipid raft association of our truncation mutants since they 
would eventually lose contact with possible anchoring proteins.  
Lipid raft localisation was determined by fractionation upon sucrose density 
gradient. The distribution of the N-terminally tagged constructs is different from the C-
terminally tagged wtPAG (Figure 2.8.). The reason why the full length N-PAG is more 
abundant in the non-raft fractions is not clarified yet. The N-terminal Flag-tag may 
interfere with palmitoylation and therefore these constructs may be losing the GEM 
targeting signal. It has been suggested earlier in connection with the PUFA treatment 
that interferes with lipid raft localisation of LAT and Lck, but does not displace PAG, that 
the extracellular and/or transmembrane domain of PAG may have a particular structure 
that attributes it with PUFA-resistance (92, 95). This special structure might be modified 
by the addition of the Flag-tag and could lead to steric inhibition of palmitoyl 
acyltransferase and inefficient palmitoylation. 
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Figure 2.8. Membrane distribution of the truncated proteins 
Rabbit-anti-Flag staining of sucrose density gradient fractions from the cells 
transfected with the indicated constructs. 
 73
Looking at the distribution pattern of the truncated mutants (Figure 2.8.) one can 
see that they are more and more excluded from the GEM fractions which reinforces the 
idea about an anchoring protein that plays a role in recruitment of PAG into the lipid 
rafts. Via shortening the cytoplasmic tail of PAG we seem to interfere more and more 
with the interaction(s) with a possible anchoring partner(s).  
 Seeing the membrane localization of N-PAG and the truncated mutants one 
could question their competence for Fyn binding site studies. Here I would like to note 
that we have shown that the palmitoylation mutant of PAG resides mainly outside of the 
lipid rafts but it is still capable of binding Fyn and the association with the non-raft pool of 
Fyn is sufficient to phosphorylate PAG (Results I/1.4.). Therefore the localisation of PAG 
does not seem to be relevant in structural studies. However, following the preliminary 
experiments where we have localised the possible Fyn binding region with the help of 
truncations, we turned back to the C-terminally Flag-tagged PAG and used it for the 
more sophisticated, site directed mutagenesis.  
 
2.5. In vitro kinase assays 
Since HEK 293T cells express high levels of the transfected truncation mutants, the 
experiments aimed at structural analysis of the Fyn binding motif were carried out in this 
cell line. As these cells express low levels of Fyn, we therefore co-transfected it and in 
this way avoided that limited Fyn results in lower phosphorylation of the PAG constructs. 
The truncated proteins as well as the full length N-PAG were immunoprecipitated from 
transfected cells and the associated Src kinase activity was measured in an in vitro 
kinase assay. The IPs were divided into two equal parts. One half was used for the IVK, 
the other served to control the amount of immunoprecipitated protein and the association 
of the binding partners. In vitro kinase assays clearly showed that while lack of the 
unconventional (STOP4) and membrane distal (STOP3) Pro-rich regions did not affect 
the phosphorylation of PAG, in the absence of the membrane proximal PRR (STOP2) it 
was completely abolished (Figure 2.9.A). Fyn IPs demonstrated on Figure 2.9.B, 
somewhat surprisingly showed association of STOP2 with Fyn. One reason why we 
could not detect kinase activity associated to the two shorter constructs may be that in 
STOP2 eight out of nine tyrosines, which are potential sites of phosphorylation, are 
deleted and STOP1 does not contain any tyrosines. 
Since the interaction between PAG and Fyn has been shown to be phospho-
independent (4) we speculated that the association of Fyn with the truncation mutant that 
still possesses a single tyrosine and no PRR (STOP2), may occur via the SH2 domain of 
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Fyn and probably has stabilizing functions. We based our hypothesis on the Fyn-FAK 
association where closely spaced proline and phosphotyrosine motifs in FAK bind 
simultaneously to both the SH3 and SH2 domains of Fyn (147). Binding of the Fyn SH2 
domain to PAG was previously shown (4, 99). Results from our laboratory with Fyn-SH2-
GST pulldowns further strengthen our idea, as they indicated Y-105 as Fyn binding site 
(Lindquist, unpublished observations). The latest publication from Davidson et al. also 
highlight that a tyrosine(s) of PAG, other than Y-314, is implicated in Fyn binding (99). 
Although we have included enolase as an exogenous substrate (74), in contrast 
to Fyn immunoprecipitates, we could not detect its phosphorylation in IVKs from Flag IPs 
(Figure 2.9.A). This could mean that PAG bound Fyn has different specificity than the 
non-bound Fyn population that is present in the Fyn IPs. To test the kinase function of 
Fyn we are planning to generate a better substrate, possibly a PAG peptide for in vitro 
kinase assays. If we assume that Fyn binds to PAG via its SH2 domain than the 
interaction should lead to an increase in kinase activity as binding via the SH2 domain 
leads to an open and thus active conformation of Src kinases (75). Finding the proper 
substrate is of importance because it would help to better understand the activatory 
mechanism and the requirement for kinase function of Fyn.  
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Figure 2.9. Fyn association with PAG truncation mutants 
A) In vitro kinase assay with Flag IPs from HEK 293T cells transfected with the indicated 
constructs. The panel on the left side presents kinase activity in Fyn overexpressing cells. The 
upper band correspond to Fyn the lower band to enolase. B) Fyn IPs stained for Flag with rabbit 
antibody. The bands of 55 and 25kDa size are the heavy and light chains of the IP-ing antibody. 
 
To demonstrate that the kinase activity observed is due to Src kinases, we 
repeated the experiment in the presence of the Src kinase specific inhibitor, PP2. Figure 
2.10. demonstrates that the phosphorylation of STOP3 and STOP4 was indeed 
abolished in the presence of Src inhibitor. 
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Figure 2.10. Phosphorylation of STOP3 and STOP4 are PP2 sensitive 
In vitro kinase assay carried out on Flag IPs from PP2 treated HEK 293T cells that were 
previously transfected with the indicated constructs. 
 
To get a better view of the Fyn binding site we have generated mutants using the 
C-terminally tagged PAG as a template to avoid any discrepancies caused by the 
dislocation of the N-terminally tagged PAG from the lipid rafts. Single mutants where the 
prolines of the membrane proximal PRR were mutated to alanine (here after referred to 
as PxxP) or where Y-105 was mutated to phenylalanine (here after referred to as 
Y105F), or the double mutant possessing both mutations (here after referred to as 
Y105F-PxxP) were generated and tested using in vitro kinase assays. In contrast to our 
expectations, kinase activity was also detected in association with the double mutant. 
Stainings of the control blots demonstrate that neither the association with Fyn, tyrosine-
phosphorylation, nor Csk binding were altered (Figure 2.11.).  
The kinase assay gave us information about the associated Src kinase activity 
(which was inhibited by the Src kinase specific inhibitor PP2), therefore the experiment 
was repeated in the JCam1.6 cell line, which is Lck deficient, to exclude Lck as the 
kinase responsible for the detected kinase activity. Since Lck is indispensable for Fyn 
activation, constitutively active Fyn was cotransfected together with the PAG constructs. 
The results obtained from JCam 1.6 cells (and also in Jurkat T-cells) were identical with 
the results from HEK 293T cells. This means that although the experiments with the 
truncated mutants identified the membrane proximal proline-rich region and Y105 as 
potential binding sites for the SH3 and SH2 domains of Fyn, respectively, the single and 
double mutants of the full length PAG still bind Fyn and PAG phosphorylation is not 
completely altered. Given the inconsistencies between the results obtained with the 
truncation mutants and the site directed mutants, we suspect that EBP-50-induced PAG  
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Figure 2.11. Fyn associates with the Y105F PxxP double mutant 
Flag IPs from HEK 293T cells transfected with the indicated constructs were prepared and 
divided into two aliquots. One aliquot was used for in vitro kinase assay (first panel). 
Western blot with the second aliquot of the Flag IPs was stained for Fyn (rabbit-anti-Fyn), 
phosphorylation (anti-phosphotyrosine-HRP) and Csk (rabbit-anti-Csk). Note, that these 
mutants were generated from the C-terminally tagged PAG construct. 
 
 
dimerisation, as previously mentioned (Results I/1.2. and Discussion I) may occur 
between the endogenous PAG and the overexpressed full length PAG constructs, which 
prevents us from detecting altered levels of Fyn association and PAG phosphorylation. 
Itoh et al. (62) published that the substitution mutant T430A is unable to bind EBP-50, 
therefore we mutated this site of the double mutant (Figure 2.12.) and plan to perform in 
vitro kinase assays with the triple mutant. If this mutation is success in abolishing Fyn 
association and the residual kinase activity detected, then we will have identified a novel 
mechanism for PAG dimerisation in addition to heaving identified the Fyn binding site. 
 
 
 
Figure 2.12. The Y105F PxxP T430A triple mutant 
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DISCUSSION II 
 
PAG has three published binding partners, Fyn, Csk and EBP-50. While the binding sites 
of Csk and EBP-50 have been identified (4, 60-62, 98), the site of Fyn association 
remains unknown despite the importance of Fyn for PAG phosphorylation. Therefore to 
further our understanding of PAG we decided to address this question. We tagged PAG 
on its N-terminus and generated a number of C-terminal truncation constructs with the 
hope of identifying the region of Fyn binding. The N-terminally tagged wild type PAG 
localised to the plasma membrane (Figure 2.7.) and was capable of binding Fyn, Csk 
and EBP-50 (see Figure 1.11. in Results I). The truncation mutants also resided in the 
plasma membrane (Figure 2.7.), however the ability of the cells to express the shortest 
construct within the plasma membrane varied among experiments and cells. This can be 
due to the lack of association with a possible membrane anchoring protein thereby 
instable membrane localisation, short half-life of the protein or failure in the 
posttranslational vesicular transport. STOP4, the mutant which still contains Y-317 
associated with Csk, as expected. 
Once we had localised the potential Fyn binding site to the region of the 
membrane proximal PRR with the help of the truncation mutants, the next step was to 
mutate the potential binding sites on the full length protein by site directed mutagenesis. 
The results obtained from in vitro kinase assays were surprising at first. Seeing that 
there was no kinase activity associated to the shorter truncated mutants lacking the 
membrane proximal proline-rich region, one would expect that the point mutations at this 
region would bring similar results. Instead, we found that neither the proline-rich region, 
nor Y-105 mutations interfered with PAG phosphorylation. The contradiction between the 
results from these two approaches i.e. truncation and site directed mutagenesis may 
result from the differently tagged PAG constructs that were used for the mutation 
studies. For the first approach N-terminal tagging of PAG was indispensable. Based 
upon our results with the palmitoylation mutant of PAG (i.e. that it binds Fyn to the same 
extent as wt PAG) we assumed that displacement from the lipid rafts does not interfere 
with Fyn binding and the non-raft associated truncated mutants are suitable for 
preliminary studies. It is obvious from our results with the palmitoylation mutant of PAG, 
that there is enough Fyn in the non-raft membrane fractions to phosphorylate PAG.  
In connection with the interesting observation that unlike LAT and Lck, PAG is not 
displaced from the lipid rafts upon PUFA treatment (95), it has been proposed that either 
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a special structure of the extracellular and/or transmembrane domain of PAG or a lipid 
raft associated anchoring partner attributes PAG with PUFA resistance (92). The unique 
structure of the amino-terminal domains might, in this case, have been disturbed by the 
N-terminal tagging. It could also lead to altered palmitoylation, which would explain the 
reduced raft association of the N-terminally tagged PAG constructs. However the fact 
that the truncated mutants are less and less detected in the lipid rafts points to the 
second explanation of PUFA resistance, namely to a possible interacting partner that 
supports lipid raft association of PAG. This may be a loose association that plays a 
minor role when PAG is palmitoylated, but if there is indeed a palmitoylation defect in the 
case of the N-terminally tagged PAG molecules the role of an anchoring protein would 
become more important. Truncation mutations could interfere with this association and 
therefore the smaller constructs would lose their ability to localise in rafts. Experiments 
with 3H palmitate would be useful to determine whether the N-terminally labelled 
constructs are palmitoylated.  
The idea of Vaclav Horejsi concerning light and heavy rafts (described in Results 
I) offers a possible explanation for the detection of the STOP mutants in the non-raft 
membrane fractions. With the help of a gel filtration method, his group has shown that 
the adaptor molecule LAX localises to the lipid rafts just like LAT. The earlier view that 
LAX is a non-raft protein was based upon the sucrose gradient method that we also 
used to determine the distribution of the PAG constructs. To clarify whether the N-
terminally tagged PAG constructs are indeed excluded from the lipid rafts or they reside 
in the heavy rafts we should apply this method. 
One possible explanation for the observed inconsistency between the results 
obtained with the truncation mutants and point mutations is that dimerisation occurs 
between the endogenous PAG and the full length mutants via EBP-50, which prevented 
us from detecting the effect of the site directed mutations. To address this possibility we 
have generated an additional T430A mutation in the EBP-50 binding site of the Y105F, 
PxxP and Y105F PXXP mutants and are planning to test these new constructs for 
associated kinase activity. 
Let us suppose that the EBP-50 binding site mutant reveals that dimerisation is 
not the reason for the remaining kinase activity associated with the Y105F, PxxP and 
Y105F-PxxP mutants. What mechanisms of interaction then remain? Fyn has been 
published to bind other proteins via its SH2 and SH3 domains (145, 147). However, 
there is one more mode of recognition that was first described for the SH3 domain of 
GADS, namely that it binds to the RxxK motif on SLP-76 (148), and also applies to the 
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SH3 domain of Fyn that binds via the same motif to the adaptor molecule SAP (146). 
Based upon these results and knowing that there is an RxxK motif within the PAG 
sequence (following the palmitoylation site), we think that the unconventional SH3 
binding site may also be a good candidate to mediate Fyn binding to PAG. The next step 
would be to generate the R42A mutant and test whether this is still capable of Fyn 
binding. This approach is reasonable given that substitution of arginine with alanine at 
the RxxK motif of SAP and SLP-76 abrogated Fyn and GADS binding, respectively (146, 
148).  
Seeing the inability of Fyn to phosphorylate enolase, the exogenous substrate in 
the kinase reaction that was previously shown to be the proper substrate for Fyn (74), in 
Flag IPs (Figure 2.9.A), it is tempting to speculate that binding to PAG results in an 
alteration of Fyn kinase activity. Further developing the idea the following hypothesis 
emerges: Fyn may phosphorylate PAG without direct interaction, like Lck phosphorylates 
LIME (75) or ZAP-70 (149) and thus induces binding via its SH2 domain in a phospho-
dependent manner. Binding of Fyn to either pY-105 or the membrane proximal PRR 
might be of sufficient strength that Fyn cannot dissociate to bind and phosphorylate other 
substrates and in this way PAG exerts an additional negative regulatory function namely 
by sequestering Fyn within the GEMs, and thus restricting the amount of available 
kinase. This is in agreement with our observations indicating that autophosphorylation of 
Fyn is altered in wt PAG overexpressing cells and is not inducible upon CD3 or SDF-1 
stimulation.  
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SUMMARY 
 
The phosphoprotein associated with GEMs (PAG) was simultaneously identified by two 
groups. One described it as a member of the Fyn complex, the other found it as a Csk 
binding protein (Cbp). According to the current model of PAG function, both of these 
associations play a crucial role in the regulation of T-cell responses.  
PAG is ubiquitously expressed, which is unique among the transmembrane 
adaptor proteins, suggesting that PAG has a more general role in regulating cellular 
functions throughout the organism. PAG belongs to the lipid raft associated group of 
transmembrane adaptor proteins. In resting T-cells, PAG is phosphorylated and binds 
Csk. Following stimulation via the TCR, a yet unknown phosphatase dephosphorylates 
PAG and thereby releases Csk, allowing Src kinases to then become activated. Lck 
translocates to the lipid rafts where it mediates Fyn activation. By phosphorylating their 
substrates the Src kinases initiate the signalling cascade, which leads to cytokine 
production and to the differentiation from resting into effector cells. One substrate of Fyn 
is PAG, so the activated kinase in turn rephosphorylates PAG enabling it to bring Csk 
back to the membrane. In this way the negative regulatory feed back loop closes, and 
the signalling cascade is silenced. In addition to binding Csk, PAG also serves as a link 
between lipid rafts and the cytoskeleton via its association with EBP-50 (ezrin-radixin-
moezin binding phosphoprotein of 50kDa). This interaction occurs between the C-
terminal TRL motif of PAG and a PDZ domain of EBP-50. EBP-50 interacts with ERM 
(ezrin, radixin, moezin) proteins, which bind F-actin. Anchoring of lipid rafts through the 
PAG-EBP50-ERM complex regulates lipid raft mobility. Following T-cell activation this 
interaction is lost allowing lipid raft aggregation and immune synapse formation. 
Based upon observations that Csk plays a role in the prevention and/or 
suppression of tumour formation and metastasis, one can infer that the PAG-Csk 
complex functions as a type of tumour suppressor that helps to inhibit the potential 
oncogenic effect of unregulated Src kinase activity.  
The aim of my thesis is to gain a better understanding of the regulatory function 
of PAG by studying the role of various motifs in localisation and Fyn binding. We 
demonstrate the importance of the palmitoylation motif in targeting PAG into the lipid 
rafts and the functional consequences of PAG dislocation. Fyn is the kinase responsible 
for phosphorylation of PAG, but unlike Csk and EBP-50, the site of interaction is still 
unknown. Via phosphorylating PAG, Fyn enables Csk recruitment to the proximity of Src 
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kinases. Identification of the Fyn binding site should help us to better understand how 
the kinase interacts with its target protein and by mutating the site of interaction, we can 
study whether direct association is necessary for phosphorylation and/or Fyn has an 
additional adaptor function. 
For LAT (linker for activation of T cells), which like PAG, is a lipid raft associated 
transmembrane adaptor molecule, it was shown that lipid modification (palmitoylation) at 
its membrane proximal cysteines is responsible for its lipid raft association. Both LAT 
and PAG possess a CxxC motif in their cytoplasmic tails in a juxtamembrane position, 
which was shown to be palmitoylated. Knowing the importance of palmitoylation for the 
lipid raft localization of LAT, we began investigating the palmitoylation mutant of PAG 
(CxxC→AxxA). To determine whether the mutated protein was still capable of being 
targeted to the GEMs, cell lysates from transfected Jurkat T-cells were fractionated upon 
sucrose density gradient. While the wild type protein does localise to the GEM fractions, 
mutation of the palmitoylation motif clearly reduces the targeting of PAG into these 
microdomains. Therefore, we can conclude that palmitoylation of the CxxC motif is 
required for the targeting of PAG into the GEMs. Next we looked to see whether 
exclusion from the GEMs had an effect upon the phosphorylation of PAG or upon its 
interactions with the known binding partners. By immunoblotting the PAG 
immunoprecipitates we could see equal tyrosine phosphorylation of both wt PAG and the 
palmitoylation mutant as well as equal association of Fyn, Csk and EBP-50. 
PAG is believed to exert its negative regulatory function by recruiting Csk to the 
GEMs. Since the CxxC mutant could also recruit Csk to the membrane, the question we 
next addressed was whether this mutant is capable of suppressing cellular activation, as 
cells over-expressing wt PAG can not be activated via CD3 stimulation. Mutation of the 
CxxC motif and thereby dislocation from the lipid rafts led to increased phosphorylation 
of several signalling molecules.  
Since Src kinases are also important in migration, we next tested our mutant in 
an SDF1-based migration assay, as SDF-1 is known to preferentially signal from within 
the GEMs. Our results indicate that while wt PAG is capable of mildly suppressing 
SDF1-induced T-cell migration, the CxxC mutant enhanced the migratory response. The 
role of PAG in regulation of T-cell migration was further proved with the help of PAG 
specific siRNA. Suppression of PAG expression in Jurkat T-cells led to increased 
migratory response, similarly to the effect of PAG dislocation from the lipid rafts. 
To explain the effects of the CxxC mutant, we hypothesised that over-expression 
of wt PAG increases the level of Csk within the GEMs, thereby creating an irreversible 
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block in activation. The CxxC mutant on the other hand could recruit Csk out of the 
GEMs and thereby relocate the block in Src kinase activation to the non-GEM 
compartment. For events occurring within the GEMs, the relocation of Csk outside of the 
GEMs has a profound effect, since it allows for an enhanced activation of Src kinases 
within the GEMs.  
To test this hypothesis, we reprobed the GEM fractions for Csk content. Indeed, 
we found that the level of Csk within the GEMs was reduced by overexpression of the 
CxxC mutant. Together these results indicate that the mechanism of action appears to 
be effected by a redistribution of Csk within the cell. If this mechanism is correct, then 
this should also be reflected by changes in the phosphorylation of activatory and 
inhibitory tyrosines of Src kinases within the GEM and non-GEM compartments. By 
reprobing the fractions with phospho-specific antisera for the activatory tyrosine of Fyn 
(pY-418) we could show that there is indeed an increase in activatory tyrosine 
phosphorylation within the GEM fractions of cells expressing the PAG CxxC mutant. 
Using Src kinase specific inhibitors the phosphorylation level of PAG was greatly 
reduced, however Fyn association was unaffected, indicating that the interaction occurs 
in a phospho-independent manner. There are several motifs apart from the 
phosphotyrosines within the PAG sequence that could support Fyn binding: PAG has 
two conventional (PxxP) and one non-conventional (PxxxP) Pro-rich regions, which are 
potential binding sites for SH3 domains, additionally an RxxK motif is located in a 
submembrane position in PAG that may also be a target for Fyn SH3 binding. As both 
Fyn and PAG are S-acylated (myristoylated and palmitoylated, respectively) one can 
also speculate that hydrophobic (lipid-lipid) interactions in or at the membrane might also 
play a role in Fyn association. 
To study the mechanism of Fyn binding, several truncation and site directed 
mutants needed to be generated. We designed the truncation mutants that would 
eliminate the potential Fyn binding sites one by one. Once we had localised the region of 
the interaction, we analysed the mechanism of binding via single mutations. Our results 
indicated that even though Fyn binding was reported to be phospho-independent, both a 
proline-rich region and the phospho-Y-105 might be involved in forming the PAG-Fyn 
complex. Such a bipartite interaction has been already published for Fyn and its binding 
partner FAK. The SH2 domain of Fyn seemingly plays a role in stabilising the interaction 
formed between the SH3 domain and the membrane proximal proline-rich region of 
PAG. By mutating the Fyn binding site we will be able to determine the functional 
consequences of Fyn-PAG association. 
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During our studies several exciting questions opened up. One of them is whether 
EBP-50 is capable to assist dimerisation of PAG molecules. Some of our observations, 
like residual lipid raft localisation of the palmitoylation mutant and the contradictory 
results with the substitution mutants at the potential Fyn binding sites, all point to EBP-50 
as a possible causative factor. Via demonstrating the role of EBP-50 in these 
observations, we would identify a novel mechanism for PAG dimerisation.  
The next interesting question of our experiments is whether application of the 
new lipid raft isolating method from Vaclav Horejsi’s lab, namely the gel filtration would 
bring different results regarding raft localisation of the PAG truncation mutants and 
whether the enigma of these constructs can be explained by the existence of the heavy 
rafts. 
The third question that we would like to clarify in the near future is the mechanism 
of Fyn binding to PAG. We hope that the T430A mutants of the EBP-50 binding will bring 
us closer to the solution. If the experiments with these mutants reveal that dimerisation 
does not play a role, we will continue our studies with the R42A mutant of PAG that aims 
to clarify the involvement of a non-conventional SH3 binding motif in Fyn association to 
PAG. Once we identify the binding site, the next step is to study the effect of mutations 
that disturb Fyn association on the fate of T-cells. Identifying the site and mechanism of 
binding will also bring us closer to understanding the nature of PAG phosphorylation by 
Fyn and a new view of negative regulation of Src kinases by PAG may also emerge from 
these studies. 
 
 84
ABBREVIATIONS 
 
ADAP   adhesion and degranulation promoting adaptor protein 
AP-1   activator protein 1 
APC   antigen presenting cell 
BCR  B-cell receptor 
BSA   bovine serum albumine 
Cbp   Csk binding protein  
Cbl   Casitas B-lineage lymphoma 
CD  clusters of differentiation 
Csk   C-terminal Src kinase 
DAG   diacylglycerol 
DMSO  dimethylsulfoxide 
DRM   detergent-resistant membrane 
EBP-50  ezrin-radixin-moezin binding phosphoprotein of 50kDa 
EDTA   ethylene-diamine tetra-acetic acid 
ER   endoplasmatic reticulum  
Erk   extracellular signal-regulated protein kinase 
FAK  focal adhesion kinase 
FCS   fetal calf serum 
FITC  fluorescein isothiocyanate 
FLIM   fluorescent life time imaging  
FRET   fluorescence resonance energy transfer  
G3BP  GAP SH3-domain binding protein 
GADS   Grb2 related adaptor protein 
GEM   glycosphyngolipid-enriched microdomain   
GPI   glycosylphosphatidylinositol  
Grb2   growth factor receptor bound protein 2 
Hck   haematopoietic-cell kinase 
Ig  immunoglobulin 
IP  immunoprecipitate 
IP3   inositol-1,4,5-triphosphate 
IPTG   isopropylthiogalactoside 
IS   immunological synapse  
ITAM   immunoreceptor tyrosine-based activation motif  
ITIM   immunoreceptor tyrosine-based inhibitory motif 
Itk   interleukin-2 inducible T-cell kinase 
LAT   linker for activation of T-cells 
LAX   linker for activation of X-cells 
Lck   lymphocyte-specific cytoplasmic protein tyrosine kinase 
ld   liquid-disordered  
LIME   Lck-interacting membrane protein 
lo   liquid-ordered  
MAPK   mitogen-activated protein kinase 
MyH9   nonmuscle myosin heavy chain IIA 
Nck   non-catalytic region of tyrosine kinase 
NFκB   nuclear factor κB 
NFAT   nuclear factor of activated T-cells 
NTAL   non-T-cell activation linker 
p62Dok  downstream of tyrosine kinase 
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PAG   phosphoprotein associated with glycosphingolipid enriched microdomains 
PAK   p21 activating kinase 
PAT   palmitoyl acyltransferase  
PBL  peripheral blood lymphocyte 
PBS   phosphate-buffered saline 
PDZ  postsynaptic density/disc-large/ZO1 
pEF-IRES polypeptide chain elongation factor 1α - internal ribosomal entry sites 
PEP   PEST enriched PTP 
PH   pleckstrin homology domain 
PI3K   phosphatidylinositol-3 kinase 
PIP  phosphatidylinositol phosphate 
PIP2   phosphatidylinositol-4,5-biphosphate 
PIP3  phosphatidylinositol-1,4,5-triphosphate 
PKB   protein kinase B 
PKCθ   protein kinase C 
PLCγ1  phospholipase C-γ1  
PP2   pyrazolopyrimidin 
PRR  proline-rich region 
PTK   protein tyrosine kinase 
PTP   protein tyrosine phosphatase  
PTPα   protein tyrosine phosphatase α  
PTP-PEST PTP with PEST sequence 
PUFA   polyunsaturated fatty acids  
PVDF  polyvinylidene difluoride 
Pyk2   proline-rich tyrosine kinase 2 
RasGRP  Ras guanyl-releasing protein 
SAP  SLAM-associated protein 
SDF   stromal cell-derived factor 
SDS-PAGE  sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SFKs   Src family kinases  
SH2   Src homology 2 domain 
SH3  Src homology 3 domain 
SHIP   SH2-containing inositol phosphatase 
SHP-1  SH2 domain containing PTP 
siRNA  small interfering RNA 
SIT  SHP-2 interacting transmembrane adaptor protein 
SLP-76  SH2 domain containing leukocyte protein of 76 kDa 
SOS   son of sevenless homologue 
TCR   T-cell receptor 
TRAP   transmembrane adaptor protein  
TRIM  T-cell receptor interacting molecule 
VAV   guanine nucleotide exchange factor 
WASP  Wiskott-Aldrich syndrome protein 
ZAP-70  Zeta-associated protein of 70 kDa 
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APPENDIX-Antibodies 
beta-actin mouse, monocl. IgG1 AC-15 WB 10000 Sigma
CD3 mouse OKT3 stimul. supernat. our institute
CD3 mouse c305 Ca-flux supernat. our institute
CD3-FITC mouse IgG1 UCHT1 FACS 100 BD Bioscience
CD29 mouse MEM101A M 1000 Dr. Vaclav Horejsi
CD59 mouse MEM43/5 WB 250 Dr. Vaclav Horejsi
Csk rabbit, polycl. IgG  C-20 WB 200 Santa Cruz 
Csk mouse IgG1 WB 500 BD Bioscience
CXCR4 rabbit, polycl. IgG WB 1000 abcam 
CXCR4 mouse FACS 100 PharMingen
EBP-50 rabbit, polycl. IgG WB-IP 10000 abcam
EBP-50 rabbit, polycl. IgG WB-lysate 25000 abcam
ERK1/2 rabbit, polycl. WB 5000 Promega
Flag rabbit, polycl. IgG M ,WB 400 Sigma
Flag M2 mouse, monocl. IgG1 WB 350 Sigma
Flag M2 mouse, monocl. IgG1 FACS, M 10000 Sigma
Fyn mouse WB, IP 1000 Dr. Vaclav Horejsi
Fyn mouse IgG1 M 50 Biosource
Fyn rabbit, polycl. WB 2000 Biosource 
Fyn rabbit M 50 Dr. Paul Burn
LAT rabbit WB 1000 Dr. Vaclav Horejsi
Lck rabbit WB 1000 Dr. Anthony Magee
MHCII mouse W6/32 FACS 100µl supernat. our institute
PAG mouse MEM255 M 50 Dr. Vaclav Horejsi
PAG mouse MEM255 WB 100 Dr. Vaclav Horejsi
PAG rabbit FACS 50 Dr. Vaclav Horejsi
PAG rabbit M 250 Dr. Vaclav Horejsi
PLC gamma rabbit WB 1000 Santa Cruz 
TRIM mouse M 300 Dr. Vaclav Horejsi
ZAP-70 mouse WB 1000 BD Bioscience
phosphospecific antibodies
pERK1/2 rabbit, monocl. WB 1000 Cell Signaling 
pPLCgamma (Y-783) rabbit WB 1000 Santa Cruz
pY-317 (PAG) rabbit WB 10 000 our intitute
pY-418 (Src) rabbit, polycl. WB 1000 Biosource
pY-505 (Lck) rabbit, polycl. WB 1000 Biosource
pY-529 (Src, Fyn) rabbit, polycl. WB 1000 Biosource
pY mouse 4G10 WB 100 our intitute
pY-HRP mouse IgG2b pY20 WB 1000 Southern Biotech
pZAP-70 (Y-319) rabbit WB 1000 Cell Signaling 
secondary antibodies
anti-mouse-HRP goat IgG WB 10 000 Dianova
anti-rabbit-HRP goat IgG WB 10 000 Dianova
anti-mouse-FITC donkey IgG FACS 250 Dianova
anti-mouse-FITC donkey IgG M 500 Dianova
anti-rabbit-FITC donkey IgG FACS 100 Dianova
anti-rabbit-FITC donkey IgG M 500 Dianova
anti-mouse-Texas red goat IgG M 200 Dianova
anti-mouse-Cy5 donkey IgG M 100 Dianova
WB - Western blot
Source
M - microscopy staining  IP - immunoprecipitation
Antibody Species Isotype Clone Usage Dilution
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